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ABSTRACT
Objective: To determine the relationship between asbestos exposure and 
chromosome damage, as depicted by sister chromatid exchange frequency. 
Design: Descriptive, cross-sectional study.
Setting: Asbestos-products factory
Subjects: 31 asbestos-exposed subjects and 21 unexposed subjects
Main outcome measure: Mean sister chromatid exchange (SCE) frequency
per metaphase cell.
\
Results: The control group had a slightly higher mean SCE frequency per 
cell than the exposed group (3.4%) but this difference was not statistically 
significant (p = 0.5935). Smoking contributed significantly to SCE frequencies 
in both the exposed and unexposed groups. The mean SCE frequencies per 
cell in the exposed group were 10.49 for smokers and 8.59 for non-smokers 
(p = 0.0078). The frequencies for smokers and non-smokers in the unexposed 
group were 10.83 and 8.58, respectively (p = 0.0257).
Conclusions: The failure to observe an increase in SCE frequency does not 
rule out asbestos exposure as a genotoxic agent. Rather, it may help to 
resolve the limitations of this method for detecting genetic damage. 
Alternatively, the fibre levels to which this group was exposed may have 
been too low to cause chromosome damage.
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CHAPTER 1: INTRODUCTION
1.1 Asbestos: uses and health effects
Asbestos is a generic name for six naturally occurring fibrous minerals from 
the amphibole and serpentine group o f rock-forming minerals. South Africa 
is the third largest producer of asbestos, after the former USSR and Canada. 
Most o f the fibre is exported and in 1988 asbestos ranked seventh among 
South Africa's non-gold mineral exports (Hart 1988).
More than three quarters of all the asbestos mined is used in the 
manufacture o f asbestos-cement products, such as prefabricated walls, 
corrugated roofing and tiles, water pipes and tanks, and garden furniture and 
flower pots. Asbestos is an important component of friction products such 
as clutch plates and brake pads for cars. It is woven into material that is 
used for heat and fire resistant clothing such as that worn by foundry 
workers and firemen. It is also used for pipe and electrical insulation. It 
increases the structural strength of the plastics used in battery cases, and 
can also be found in heaters, ovens, toasters, hair dryers and polyvinyl 
chloride (PVA) floor tiles (Hart 1988). Because the asbestos industry is so 
large, many people are exposed to the fibre during the course o f their work.
A  number o f diseases have been associated with asbestos exposure, including 
many cancers. The strong association between exposure to crocidolite, or
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blue asbestos, and the development of mesothelioma (a cancer which affects 
the pleura o f the lung, in most cases) was first demonstrated by Wagner 
al. (1960) in South Africa. Other cancers have also been associated with 
asbestos exposure, although the evidence for the association is weaker than 
that for mesothelioma. These cancers include lung cancer, gastrointestinal 
tract cancers (Mossman and Gee 1989), and cancers of the bladder (Puntoni 
et al. 1979) and kidney (Selikoff et al. 1979, Enterline et al. 1987). Despite 
the health risks associated with asbestos, the fibre is still widely used.
1.2 Detection of DNA damage
There is growing concern about possible mutagenic and carcinogenic effects 
o f genotoxic agents in human populations exposed to these agents 
occupationally, environmentally or by lifestyle (Carrano andNatarajan 1988). 
For many years efforts have been made to protect populations from the 
harmful effects o f chemical substances. In Norway especially, special 
attention has been paid to genotoxins and carcinogens with a view to 
establishing a general labelling o f all carcinogens. The Norwegian authorities 
agreed to have a warning printed on all products containing 0,1% by weight 
or more o f one of several carcinogens on the "cancer list". By June 1981, 106 
substances were classified in the Norwegian cancer list. The criteria for 
classification are based primarily on human epidemiology and long-term 
experiments in animals (Brogger 1982a).
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Unfortunately, there are relatively few direct methods to measure mutations 
(unrepaired DNA damage that develops into a permanent heritable alteration 
when the damaged molecule is replicated) or other forms o f induced damage 
in humans exposed to potential mutagens or carcinogens. One o f the few 
direct methods which does exist measures gross changes occurring in the 
deoxyribonucleic acid (DNA) that can be visualised by looking at 
chromosomes through the light microscope. These alterations include overt 
breakage and rearrangement o f the chromosomes within the cell (structural 
chromosome aberrations) and more subtle changes involving the switching o f 
parts o f a single chromosome (sister chromatid exchange). The technique 
chosen for this study, to quantify chromosome damage in a group of asbestos 
workers, was sister chromatid exchange (SCE).
1.3 Sister chromatid exchange and genetic damage
A  prerequisite for the successful prevention o f neoplastic disease is the 
identification o f persons at risk either of having offspring with hereditary 
defects or o f developing disease from mutation in somatic cells (Brogger 
1982b). Persons may be at risk either because of an inherited genetic defect 
or because of exposure to environmental genotoxins, i.e. agents that cause 
a change in the quality or quantity o f the DNA in any o f the cells o f an 
individual. In the latter case, prevention requires identification o f the 
genotoxin and termination o f exposure.
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Carcinogens are thought to act by causing mutations which can be divided 
into two categories, viz. microlesions which are visible at only the molecular 
level, and macrolesions (such as those depicted by SCEs) which are visible at 
the chromosomal level (Hemminki et 1979).
The identification o f a human carcinogen is a long process. The disease 
manifests itself many years after onset o f exposure and it may take 15 to 20 
years before reliable epidemiological evidence o f an association is available 
(Brogger 1982c). To avoid such a delay, animal experimentation is often used 
to identify carcinogens. However, this experimentation is time-consuming 
and expensive, and the implications for human health are uncertain. The SCE 
test, using cultured human cells, is a quick and efficient method for 
detecting chromosome damage.
SCE is a symmetrical exchange o f genetic material between the two 
chromatids of a metaphase chromosome before the separation of the 
replicated material into two daughter chromosomes (Brogger 1982d). It 
involves breaks in the DNA sequences o f each chromatid, followed by the 
interchange o f DNA chains, and the subsequent repair o f breaks with no 
alteration o f the overall morphology (Perry and Evans 1975). The finding that 
these exchanges arise during replication on damaged templates (Wolff et al. 
1974, Kato 1980) led to the possibility o f using the SCE technique to identify 
potential DNA-damaging agents (Perry and Evans 1975).
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SCE is believed to reflect damage to the DNA material which, if the 
exchange involves errors, results in possible mutations. If a mutation occurs 
in a germ cell (oocyte or spermatocyte), the e ffec t is hereditary, i.e. the 
offspring will be affected with the possibility o f congenital malformations. 
A  change in a somatic cell (any cell o f the body, other than a germ cell) is 
transmissible only horizontally to daughter cells, an event significant in the 
aetiology o f cancer (Brogger 1982b, Hemminki 1979, Albertini et al.
1993). Thus, SCE is not only a good indicator o f mutagenic alterations in 
DNA but also a fairly reliable signal o f alterations which lead to 
carcinogenesis (Carrano et al. 1978, Abe and Sasaki 1982, Popescu and 
DiPaolo 1982).
Even if the exchange is error-free, and not harmful in itself, it still indicates 
exposure to an agent that may cause damage. In either case, exposure to a 
hazardous agent is indicated and therefore SCE can be used in occupational 
monitoring as an indirect measure of possible mutation and an indicator of 
potential health risks (Husum 1987).
So far there is no clear observational evidence for any hereditary e ffec t in 
man from exposure to mutagens (Brogger 1982b). Negative findings, 
nonetheless, have not deterred efforts to protect human populations from 
environmental mutagens (Brogger 1982b).
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The first observations that SCEs could be readily induced by alkylating 
agents (Abe and Sasaki 1977, Kato 1973, Latt 1974a, Perry and Evans 1975, 
Solomon and Bobrow 1975) led to a large number of studies, but not all (Latt 
and Schreck 1980, Latt et al. 1981, Perry 1980, W olff 1977) supported the 
idea that an agent's ability to induce SCEs correlated well with its 
effectiveness as a mutagenic carcinogen. However, controversies surrounding 
the ability o f some agents (e.g. tumour promoters) to induce SCEs (Fujiwara 
et al. 1980, Kinsella and Radman 1978, Loveday and Latt 1979, Nagasawa 
and L ittle 1979, Popescu et al. 1982, Schwartz et al. 1982, Thompson et al. 
1980) may have been resolved, to some extent, by demonstrations that these 
agents can have indirect effects; for example, induction of free radical 
production by certain cell types, with the radicals then producing the DNA 
damage (Emerit and Cerutti 1981, Emerit etal. 1982, Weinberg 1982, Emerit 
1984).
Some typical cancer-promoting agents do induce SCEs in , e.g. phorbol 
esters (Kinsella and Radman 1978). However, in members o f families with 
high cancer incidence, SCE frequency has not been found to be higher than 
normal (Cheng et al. 1979). Although there is no definite correlation between 
chromosome damage and the development o f cancer, a number o f 
carcinogenic substances have been proven to cause chromosome damage, e.g. 
benzene (Fredga et al. 1982), ethylene oxide (Yager et al. 1983, Tates et al. 
1991), and vinyl chloride (Hansteen et al. 1978).
6
The SCE technique has been used to estimate individual cancer risk. For 
example, Hopkins and Evans (1980) found that the SCE frequency in response 
to smoke condensate treatment was significantly higher in smokers with lung 
cancer than in healthy smokers or non-smokers. This suggests that smokers 
with lung cancer develop DNA lesions, measured by SCEs, more readily than 
those smokers without cancer (Vainio 1981).
Some investigators have postulated that chromosome instability, as reflected 
by quantitative changes in SCE, may signal changes associated with the 
pathogenesis o f malignancy (Livingston et al. 1983). This is supported by 
studies showing elevated SCE levels in malignant lymphoma (Kurvink et al. 
1978a), acute lymphoblastic leukaemia (Otter et al. 1979) and Bloom's 
Syndrome (Chaganti et al. 1974).
1.4 History of sister chromatid exchange
The possibility o f exchanges between sister chromatids was first suggested 
in 1938 by McClintock, as an explanation for the behaviour o f dicentric ring 
chromosomes in somatic maize cells (McClintock 1938). It was not until the 
1950s, however, that SCEs were cytogenetically demonstrated, by Taylor and 
co-workers, using autoradiographic techniques (Taylor et al. 1957, Taylor 
1958). They demonstrated the formation o f SCEs in plant root-tip cells 
following the incorporation of tritiated ( H) thymidine into replicating DNA. 
SCEs were seen as switches in the radioactive label between chromatids at
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the second mitosis after H-thymidine labelling at the S phase of the first 
cycle o f mitosis (Taylor 1958). In 1960, Taylor published a report on SCEs in 
human cells in culture.
In 1972 Zakharov and Egolina described a new method for detecting SCEs, 
incorporating 5-Bromodeoxyuridine (BrdU) into the sister chromatids instead 
o f a radioactive label (see section 3.3 for further discussion). This vastly 
improved technique resulted in a much higher resolution o f SCEs and has 
been used for their detection ever since.
Implicit in the early work of Taylor (1958) and later substantiated by others, 
was the ability o f at least one exogenous agent to induce SCEs. This was 
extended to include ultraviolet light or alkylating agents, using either 
autoradiography (Kato 1973) or the BrdU method (Kato 1974a, Latt 1974b, 
Perry and Evans 1975, Solomon and Bobrow 1975) to detect the SCEs. 
Consequently, it was suggested that SCE could be used as a possible test for 
certain types of DNA damage (Latt 1974b).
1.5 Mechanism of sister chromatid exchange
It has been suggested that SCE is a means by which a cell copes with DNA 
damage (Brogger 1982d). In some way the replicating machinery bypasses 
unrepaired DNA damage by producing an SCE (Evans 1977, Shafer 1982). 
Thus, increased DNA damage leads to increased SCE. Alternatively, SCE
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might be a slightly unreliable process in which unequal exchange is taking 
place; too small to be recognised cytologically but large enough at the 
molecular level to lead to duplication-deficiency chromatids (Brogger 1982d).
It is unclear just how SCE induction can generate genetic damage if, as is 
apparent at a cytological level, it reflects a precise reciprocal exchange o f 
genetic material. Perhaps because of errors in DNA replication enhanced 
during bypass o f DNA damage, which may be involved in the generation o f 
SCEs (Latt 1982, Shafer 1977, Tatsumi and Strauss 1978), the exchange might 
not be absolutely perfect. Alternatively, SCE formation may serve as a 
'signature' o f some other process which, like SCE formation, accounts for 
only a fraction o f the total DNA damage, but which, unlike SCE formation, 
can be directly linked to some mutagenic or carcinogenic process (Latt 
1984a).
The exact mechanism of SCE formation is unknown but it is thought to 
reflect changes in DNA resulting from adduct formation or changes in 
conformational structure after exposure to exogenous agents (Yager et al. 
1983). The many examples linking DNA sequence rearrangement to neoplastic 
changes (Cairns 1981, Klein 1981) suggest that DNA interchange is a possible 
mechanism linking the biological consequences and cytological 
manifestations o f cellular responses to DNA damage that induces SCEs (Latt 
et al. 1984b).
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SCEs are double-strand exchanges between polynucleotide chains of 
corresponding polarity. The DNA strand breakage (which interrupts the 
continuity o f the strands) and reunion occur during the S phase, independent 
o f the time in the cell-cycle at which the responsible DNA alteration 
occurred (Speit et al. 1984a). The general assumption of a connection 
between certain types of DNA damage and SCEs is due to the fact that 
agents responsible for characteristic types of DNA damage can also induce 
SCEs. However, none of the well-known DNA damages has been proven to be 
a necessary requirement for SCEs (W olff 1977, Cassel and Latt 1980, Duncan 
and Evans 1982).
For example, Speit et al. (1984b) studied the involvement o f single strand 
breaks (a form o f DNA damage) in the formation o f SCEs and chromosome 
aberrations. They showed that various chemicals and physical agents can 
cause single strand breaks in DNA and can also induce SCEs and chromosome 
aberrations. This connection has also been demonstrated by other 
investigators (Bradley et al. 1979, Perry and Evans 1975, Gebhart and 
Kappauf 1978, Kato 1974b, Ikushima 1977, Moan et al. 1980, Speit et al. 
1982). It was unclear, however, whether there was a causal connection 
between the induction o f single strand breaks and SCEs.
As SCEs involve the breaking and subsequent double strand exchange o f two 
identical DNA molecules, a break in one polynucleotide chain could represent
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a favourable starting point for the development o f an SCE (Speit 
1984c). One o f the early models o f SCE proposed by Kato (1974b) was based 
on this consideration. However, DNA single strand breaks do not seem to be 
a necessary requirement for SCEs (Bradley et al. 1979) and involvement of 
single strand breaks has not been directly demonstrated. Furthermore, since 
X-rays and other DNA-breaking agents are not very efficient in the induction 
o f SCEs, it has been assumed that single strand breaks do not represent a 
major pathway for the production of SCEs (W olff 1978).
The more recent models o f SCE formation assume that the required breaks 
in the DNA strands are enzymatically induced (Ishii and Bender 1980, Painter 
1980). In the model by Ishii and Bender, breaks are induced at the replication 
fork as the result o f damage. Painter postulates that the breaks frequently 
occur at the connections between neighbouring replicon clusters during their 
replication, and that SCEs are initiated whenever daughter strands o f a 
replicating cluster recombine with daughter strands of a partially replicated 
cluster. Such situations particularly occur when the fork displacement rate 
is reduced, and this is why agents blocking DNA-fork displacement are 
supposed to lead to increased SCE formation (Painter 1980).
The general replication bypass model suggests that SCEs result from a 
temporal encounter between the arrival o f replication at the site o f DNA 
damage and the simultaneous occurrence o f a particular lesion which
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impedes the normal advance o f replication (Shafer 1984a). This implies that, 
in most cases, the lesion itself does not induce the SCE. Rather, an SCE is 
more likely due to some intermediate stage o f lesion repair involving an open 
strand incision o f the DNA. SCEs thus result from switching o f incised 
parental strands at, or adjacent to, a lesion site in order for replication to 
continue past that site (Shafer 1984a).
Central to this general replication bypass principle is the concept that an 
SCE will only be induced under specific temporal interactions, i.e. not when 
lesion repair is completed before replication occurs at that site, or when 
lesions are not repaired but are o f a type which does not inhibit replication 
(Shafer 1984b). Thus, few potential SCE-inducing lesions will actually result 
in an SCE, and SCEs, like mutations, are a relatively rare outcome o f many 
DNA lesions which may have been present, whether endogenous or induced.
In addition, it was noted that many o f the agents which induce SCEs, 
whether directly or indirectly, result in a few common repair intermediate 
stages including endonuclease binding to DNA, strand incision, DNA 
resynthesis, and ligation (Shafer 1984b). It was suggested that this might be 
a basis for hypothesising a few primary SCE mechanisms to handle the wide 
variety o f agents or conditions that impede the successful completion o f 
DNA replication. The evolution o f multiple SCE mechanisms would thus be 
analogous to the evolution of multiple repair mechanisms, i.e. a small class
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o f general SCE processes designed to handle a wide variety o f discrete lesion 
conditions (Shafer 1984b).
Independent o f whether DNA lesions lead to SCEs directly or indirectly (for 
instance, via replication delay), and whether there is one or several 
mechanisms leading to SCE formation, one must assume that SCE formation 
is a complex enzymatic process which includes both the breaking and 
rejoining of DNA strands. The breaks must obviously occur in a defined 
manner so that an orderly reunion becomes possible (Speit 1984d).
Whatever the mechanism o f SCE formation, the predictability o f a genetic 
hazard by SCE induction is o f value, at least to the extent that it warrants 
subsequent examination by more complicated tests (Latt et al. 1984c).
1.6 Advantages o f the sister chromatid exchange test 
Cytogenetic analyses yield qualitative information and rough quantitative 
estimates o f the degree of exposure to mutagens (Vainio and Sorsa 1983). 
SCE analysis is a more sensitive method than conventional metaphase 
analysis o f chromosome aberrations, especially directly following the 
exposure in question (Vainio and Sorsa 1983). Large increases in the number 
o f SCEs occur with doses of mutagenic agents well below the level needed 
to cause chromosome aberrations, thus the analysis o f SCEs is a very 
sensitive method of assessing DNA damage. If cells are exposed to chemicals
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at concentrations as low as one hundredth that necessary to produce 
chromosome aberrations, large numbers o f SCEs can be seen (Latt 1974b, 
Solomon and Bobrow 1975, Perry and Evans 1975). It is also likely that SCEs 
are more representative of events compatible with cell survival (such as 
mutagenesis) than are aberrations (W olff 1977).
In conclusion, because of its sensitivity and ease o f scoring, the SCE test has 
been used increasingly as a short term test for the detection o f mutagenic 
carcinogens; an excellent correspondence has been found between chemicals 
that induce SCEs and those that induce mutations, as determined by a 
battery o f other short-term tests (Wolff 1983).
1.7 Interpreting sister chromatid exchanges
The most important health effects o f induced chromosome damage are, 
perhaps, the changes which functionally alter the cell but leave it capable 
o f proliferation. Changes at the chromosomal level may play an important 
role in carcinogenesis, e.g. in the promotion o f the malignant potential o f the 
transformed cell through an expression of the initiated oncogenic factors o f 
the genome (Vainio and Sorsa 1981).
Visible chromosome damage in a sample of somatic cells taken from an 
exposed individual provides a direct indication o f exposure to clastogenic 
agents (agents which break chromosomes). Even though the unrepaired
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damage in the indicator cells may be lethal to the cell, and thus o f no 
significance as such (especially in the case o f non-dividing T lymphocytes), 
the observation o f chromosome damage suggests that alterations of genetic 
material may also have occurred in cells o f other tissues (Vainio and Sorsa 
1981). Visible deimage also indicates that invisible lesions may have 
occurred. Such microlesions may have an even higher probability o f being 
transmitted in cell proliferation and thus, for being manifested (Vainio and 
Sorsa 1981).
The significance of chromosome mutations inherited in the germinal cell line 
has been clearly documented in relation to spontaneous abortions and live 
births with chromosome anomalies (Vogel 1979). However, as yet, there is no 
clear evidence that a population exposed to chromosome-breaking agents 
would show an increased incidence o f constitutional chromosomal or genetic 
abnormalities among their offspring (Vainio and Sorsa 1981).
On an individual basis, increased somatic chromosome damage that is clearly 
above the level o f the average o f the group may point to an inherited 
susceptibility o f the individual to, for example, develop cancer. The role of 
chromosomes in human cancer proneness is supported by correlations o f high 
chromosome instability (both ’spontaneous' and induced) and an increased risk 
of malignancies in such human hereditary disorders as xeroderma 
pigmentosum, ataxia telangiectasia, Bloom's syndrome, and Fanconi's
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anaemia (Knudson 1977). The quantitative estimate o f risk cannot, however, 
be deduced from the chromosomal data o f a single individual (Vainio and 
Sorsa 1981).
Although an individual prognosis cannot be derived on the basis o f 
chromosome data, we may suspect that an individual with a prolonged 
increased level o f somatic chromosome damage has been exposed to an agent 
at concentrations high enough to cause ill health effects (Vainio and Sorsa 
1981).
In terms o f potential genetic hazard to a population, the production of a low 
level o f damage in a large number o f individuals is o f greater consequence 
to the population than the induction of large amounts o f damage in a small 
number o f individuals (O'Riordan and Evans 1974). On the group level, the 
demonstration of chromosome damage can be considered proof o f genotoxic 
risks requiring actions to decrease exposure (Vainio et al. 1981).
One may conclude that a group o f exposed persons showing increased levels 
o f chromosome damage has a higher risk o f developing cancer than a group 
showing no such increase.
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1.8 Factors affecting sister chromatid exchange frequency in individuals
SCEs arise spontaneously, and in fairly large numbers per cell, on average, 
in the absence o f genotoxin exposure (Bender 1992). Nevertheless,
there is considerable variation in the SCE frequency in lymphocytes o f 
healthy human subjects (Lambert et al. 1976, Lambert et al. 1978, Morgan 
and Crossen 1977, Crossen et al. 1977, Pedersen et al. 1979). Different 
studies have reported mean baseline SCE frequencies per cell from as low as 
4.41 to as high as 14.26 (Table 1).
TABLE 1. Baseline sister chromatid exchange frequencies 1n normal 
populations
Reference Country SCE/cel1
range mean SD
Galloway and Evans 1975 Britain 12.19 - 19.96 14.26 ns
Latt et a 7. 1975 USA 9.50 - 14.60 12.50 ns
Hatcher et a 7. 1976 USA 7.20 - 10.60 8.70 2.73
Morgan and Crossen 1977 New Zealand 1.00 - 12.00 7.90 1.36
Hollander et a 7. 1978 USA 9.80 - 15.00 11.90 1.77
Lambert et a 7. 1978 Sweden 7.80 - 20.00 13.20 2.90
Cervenka et a 7. 1979 Nigeria 4.80 - 6.33 5.20 ns
Meiying et a 7. 1982 China 3.70 - 5.75 4.41 0.72
Hirsch et a 7. 1984 USA 6.63 - 9.61 8.26 0.79
Soper et a 7. 1984 USA 5.00 - 17.50 9.90 2.00
Bender et a 7. 1992 USA < 4.40 - 13.40 8.12 ns
Park et a 7. 1992 Korea 3.49 - 16.96 8.78 0.24
Anderson et a 7. 1993 UK ns 6.69 ns
ns = not stated
The higher baseline frequencies o f SCE in populations o f developed countries
(compared to those in developing countries) may be due to higher
environmental contamination (Meiying et al. 1982).
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In most investigations, groups for study are selected from a "normal” human 
population. It is therefore important to know which factors may influence 
the baseline SCE variation. Genetic differences are one possible explanation; 
SCE has been found to be relatively consistent in repeated cultures for the 
same donor (Morgan and Crossen 1981, Morgan and Crossen 1977, Crossen 
al. 1977). Pedersen et al. (1979) studied mono- and dizygotic twins and found 
the same variation within pairs as between pairs.
Studies demonstrating the e ffec t o f age on SCE frequency have shown 
conflicting results. Some authors have reported no differences across wide 
age ranges (Morgan and Crossen 1977, Galloway and Evans 1975, Schneider 
et al. 1979). Other studies have demonstrated differences between children 
and adults (Funes-Cravioto et al. 1977, Ardito et al. 1980, Schuler et al. 
1979, Murthy et al. 1980). Zanzoni et al. (1979) reported a significant 
difference between 20 to 40 year olds, and 60 to 80 year olds. Goh (1981) 
showed a higher SCE frequency in 66 to 88 year olds than in 24 to 65 year 
olds. On the other hand, Wen and Liew (1983) found a significant correlation 
between age and SCE frequency in non-smokers between 13 and 84 years of 
age. Other reports have also described increases with age (Waksvik et al. 
1981a, Sarto et al. 1985).
When genetic factors are ruled out, differences in environmental exposure 
levels must be considered as a cause for variation.
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Tobacco smoke is the most widespread exposure in the human population 
(Hansteen 1982a). Many studies have demonstrated an increase in SCE 
frequency among cigarette smokers (Murthy 1979, Reuterwall 1990, Lambert 
et al. 1978, Degrassi et al. 1993). The amount o f smoking, inhalation, and
even the time between smoking and collection o f the blood sample may 
influence the SCE frequency (Lambert et al. 1982a). Smoking has been shown 
to increase the frequency of SCEs by between five and 23% (Nordic study 
group 1990, Bender et al. 1988, Reidy et al. 1988).
Other factors affecting SCE frequency include anticancer drugs (Jacobson- 
Kram et al. 1993), organic solvents (Funes-Cravioto et al. 1977), ethylene 
oxide (Stolley etal. 1984), oral contraceptives (Lambert et al. 1982b, Murthy 
and Prema 1979), caffeine (Reidy et al. 1988, Shim 1989) severe protein 
malnutrition (Murthy et al. 1980), infection o f the urinary tract (Kowalczyk 
1980), vaccinations (Lambert et al. 1979), and hepatitis, herpes simplex virus 
and uncharacterised cold or influenza virus infections (Kurvink etal. 1978b).
Increased SCE frequency has been reported in females (Hedner et al. 1982, 
Bender et al. 1988), and single XX cells have been shown to have a higher 
SCE frequency than X Y  cells (Wulf and Niebuhr 1985). This is believed, by 
some authors (Margolin and Shelby 1985, Bender et al. 1988), to be due to the 
longer second X chromosome in females, in relation to the Y  chromosome in 
males. Wulf (1990), however, states that this difference is too large to be
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solely due to the different genomic lengths of the X  and Y  chromosomes.
Whatever the reason, sex must be considered as a confounding factor in SCE 
studies.
Studies o f in vivo exposed persons are also complicated by variation in the 
dose o f individual exposure which is often difficult to determine in 
retrospective studies (Hansteen 1982a). Distribution o f the test chemical in 
the body, the metabolic activation o f the compound, and the rate of 
inactivation of the metabolites are unknown for most chemicals. Metabolic 
activation, inactivation of metabolites, and DNA repair processes may also 
be subject to genetically determined individual variation. Therefore, it is 
also difficult to make dose estimates in prospective studies.
A ll o f the aforementioned factors can influence SCE and consequently mask 
the e ffec t o f the particular agent being tested. A  precise characterisation 
of the subjects under study is therefore crucial in an investigation which is 
designed to evaluate the e ffec t o f a particular industrial or environmental 
toxin. The exposed subjects and their referents should ideally be a 
homogenous group with regard to all exposures except the one under scrutiny 
(Hansteen 1982b).
The possible environmental exposures that may influence the baseline SCE 
frequency underline the extreme importance o f collecting detailed
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information on age, smoking habits, drugs, alcohol, recent viral infections, 
hobbies, etc., for all subjects under investigation (Hansteen 1982a).
1.9 The distribution of sister chromatid exchanges within chromosomes 
Although SCEs seem to occur randomly in that they are distributed among 
the chromosomes according to Poisson expectations, there are several 
indications that their location within chromosomes might not be completely 
random. A  large proportion o f SCEs occur in the interband regions o f G- 
banded chromosomes (W olff 1977).
1.10 Sister chromatid exchange and occupational exposures
Once an increased incidence o f cancer in an industry becomes evident, the 
opportunity for prevention of the disease is lost. Latency time between 
primary damage and expression may be many years. It is therefore important 
to detect potential ill health effects before they occur. SCEs can be used in 
occupational monitoring as an indirect measure o f possible mutation and an 
indicator o f potential health risks (Husum 1987, Gebhart et al. 1993). Visible 
chromosome damage in a sample o f somatic cells taken from an exposed 
individual provides a direct indication of possible exposure to clastogenic 
agent(s). Cytogenetic monitoring o f suitable occupational groups is a feasible 
method to identify individuals and populations with potential genotoxic risk 
(Sorsa 1985).
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SCE frequencies may be affected by individual differences in metabolism and 
susceptibility to chemicals (Degrassi 1993). Other problems with In
vivo studies lie in identifying a specific factor in an occupational setting, 
where simultaneous exposure to a number o f organic and inorganic chemicals 
is a common phenomenon (Vainio and Sorsa 1981). The interaction between 
different agents may a ffect the properties o f one or the other, for example, 
toluene modifies the metabolism and toxicity o f hexane (Takeuchi et al. 
1993). The use o f the SCE technique in occupational settings is also hindered 
by limited information on the distribution of SCE frequencies in non-exposed 
persons (Soper et al. 1984).
TABLE 2. Increased sister chromatid exchange frequencies 
observed in some occupational settings
Agent Reference
Anaesthetic gases 
Chromium
Coke oven emissions 
Cytostatic drugs 
Ethylene oxide 
Lead
Organic solvents
Organophosphate (insecticide)
Pentach1orophenol
Petroleum
Pesticides
Stone dust (silica)
Styrene
Toluene
Trich1oroethy1ene 
Vinyl chloride
Karelova et a 7. 1992 
Stella e t  a l . 1982 
Miner et a l . 1983 
Norppa et a l . 1980 
Stolley et a l . 1984 
Mak1-Paakkanen et a l . 1981 
Funes-Cravioto et a l . 1977 
Larripa et a l . 1983 
Bauchinger et a l . 1982 
Edwards and Priestly 1993 
De Ferrari et a l . 1991 
Sobti and BhardwaJ 1991 
Andersson et a l . 1980 
Bauchinger et a l . 1983 
Gu e t  a l . 1981 
Kucerova et a l . 1979
Many studies on different occupational exposures have demonstrated 
increased SCE frequencies in workers (Table 2). Not a single case, however, 
has been observed in which it is evident that increased SCE in lymphocyte
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chromosomes led to a hereditary defect or a cancer (Brogger 1982e). 
Nevertheless, workers exposed to vinyl chloride monomer have developed 
angiosarcoma of the liver (Creech and Johnson 1974) and exposures o f similar 
levels have been large enough to induce both SCEs and chromosome 
aberrations (Hansteen et al. 1978).
Large prospective studies are perhaps the only way o f obtaining reliable, 
quantitative estimates o f the risks indicated by observed SCE increases 
(Brogger 1982f). In occupational health, exposures leading to increased SCE 
and chromosome aberration call for immediate efforts to diminish the 
unwanted exposure (Brogger 1982f).
1.11 Sister chromatid exchange and asbestos
Many researchers have investigated the relationship between in vitro 
exposure o f different types of cells to asbestos and SCE frequency but 
results have been inconclusive (Table 3).
Very few  studies have been done on the in vivo effects o f asbestos. Bajerska 
et al. (1988) found an increase in SCE frequency in mouse bone marrow cells 
after in vivo exposure to asbestos. Only three reports on human exposure to 
asbestos and SCE have been published (Rom et al. 1983, Fatma et al. 1991, 
Kelsey 1986a), with contradictory findings (see chapter 5).
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TABLE 3. Sister chromatid exchange studies on In  v i t r o  
exposure to asbestos
Reference Cell Type Increase 1n SCE
Livingston e t  a 7- 1980 CHO fibroblasts Yes
Kaplan e t  a 7. 1980 RPM cells No
Price-Jones et a 7. 1980 V79-4 CH cell line No
Babu e t a 7. 1981 CHO cells Yes
Casey 1983 CHO, human fibroblasts No
and lymphoblastold lines
Hei et a 7. 1985 mouse embryo fibroblasts No
Kelsey et a 7. 1986b CHO cells No
Archard et a 7. 1987 RPM cells Yes
CHO - Chinese hamster ovary
RPM - rat pleural mesothelial
1.12 Objective o f the study
The objective o f the study reported here was to determine the relationship 
between asbestos exposure and chromosome damage, as depicted by sister 
chromosome exchange frequency.
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CHAPTER 2: METHODS
2.1 Study population and sampling
The study population consisted of two groups o f black males, viz. a group 
exposed to chrysotile asbestos and an unexposed reference group. The 
exposed group originated from two neighbouring asbestos products factories 
(factories A  and B) which manufactured brake linings, asbestos heaters, etc. 
The reference group comprised men such as cleaners and clerks, employed 
in a Government institute and not exposed to asbestos at work. The two 
groups were o f similar socio-economic status.
A  total exposed sample of 122 workers was selected from the two factories. 
A ll workers (61) were selected from factory A  and a further 61 were 
randomly chosen (using random numbers generated by the computer package, 
Epistat) from the 115 workers in factory B. Sixty one of the 63 men in the 
reference group were selected. The study sample thus comprised 122 exposed 
and 61 unexposed subjects (a ratio o f 2:1).
For the purpose of analysis, the workers from factory A  and those sampled 
from factory B were combined into a single asbestos-exposed group.
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2.2 Implementation
Eighteen cases were randomly selected each week for a period of 10 weeks 
(six from each o f the two factories and six from the reference group). Each 
study subject was given an explanation about the research being conducted 
and an informed consent form was signed if  he agreed to participate 
(appendix 1).
In one day two questionnaires were administered by two trained interviewers 
and a 10ml sample of blood was drawn, in a heparinised vacutainer tube, 
from each person. The first questionnaire (appendix 2) covered basic 
demographic information, family history (with regard to birth abnormalities), 
smoking history, health status, and other information about exposure to 
factors known to increase the frequency o f SCE. The second questionnaire 
(appendix 3) dealt with previous and present exposure to asbestos, and 
occupational histories.
2.3 Culturing o f cells for sister chromatid exchange analysis 
One day later, T lymphocytes were cultured from each o f the blood samples, 
according to standard techniques (described below), in a "batch” . In other 
words, all the blood samples were prepared at the same time in a uniform 
manner to overcome problems relating to culturing cells under different 
conditions (see 3.4 - factors influencing SCE in culture). A t the end o f the 
study there were 10 such batches o f cells.
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Double cultures (two cultures per study subject) were initiated in sterile 
15ml plastic screw top centrifuge tubes by adding 0.5ml heparinised blood to 
4ml Ham's F-10 medium with L-glutamine and antibiotics, 0.5ml foetal 
bovine serum, and 0.05ml phytohaemagglutinin. Lastly, 0.3ml BrdU 
(concentration lOug/ml) was added. The tubes were then wrapped in 
aluminium foil to protect the cells from light. The cultures were incubated 
at 37°C, at an angle o f approximately 30°, for 72 hours. Thereafter, 0.1ml 
of colchicine (concentration 0.05ug/ml culture medium) was added to each 
5ml culture. Thirty minutes later the cultures were terminated by 
centrifuging at 1 600 rpm for 10 minutes, removing the supernatant, and 
adding 5ml o f 0.075M KC1 at 37°C. The cultures were incubated at 37°C for 
a further 20 minutes, after which the tubes were again centrifuged and the 
supernatant removed. The cells were "fixed" by adding 5ml fixative (three 
parts methanol to one part glacial acetic acid) to each culture, centrifuging, 
and removing the supernatant. This process was repeated until the 
supernatant was clear. Usually, three fixative changes were sufficient.
2.4 Microscope slide preparation
Two microscope slides were prepared from the lymphocyte cultures of each 
study subject. Pre-cleaned slides were soaked in absolute alcohol for at least 
24 hours at room temperature; they were then dried and polished with facial 
tissue. Approximately 0.5ml fixative was added to the cell pellet 
immediately before preparing the slides and the cells were resuspended,
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using a narrow calibre glass pipette. The slides were flooded with cold
fixative and the excess was tipped o ff. Three to four drops of the cell 
suspension were dropped onto each slide from a height o f approximately one 
metre. The slides were again gently flooded with fixative as they began to 
dry. Once they had air dried completely, the slides were stored for four days 
at room temperature before being stained.
2.5 Slide staining
The staining procedure followed was a modification by Crossen (1982a) o f the 
fluorescence plus Giemsa (FPG) technique developed by Perry and W olff 
(1974). The slides were stained for 15 minutes in a lOOug/ml 33258 Hoechst 
stain (a bis-benzimidazole fluorochrome), rinsed in distilled water, dried, and 
mounted in 0.6M Na2HP04 (anhydrous). A fter being exposed to natural light 
for 24 hours, the coverslips were removed and the slides were incubated for 
20 minutes in 0.06M phosphate buffer (0.06M Na2HP04/KH2P04; pH 6.8). 
They were then stained in a 5% Giemsa solution (Gurr R66) for six minutes.
2.6 Microscopic analysis of sister chromatid exchange
Each slide was given an identification number to ensure that the counting o f 
SCEs was a blind procedure, i.e. the reader was unaware o f the exposure 
status of the individual when counting the SCEs, and observer bias was 
prevented. A ll the slides were examined by a single reader.
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The cells were examined under 1 000 X magnification (oil immersion), using 
a Nikon Alphaphot YS microscope, and a drawing tube. Each change in colour 
along the length of a chromatid was counted as an SCE (see Fig. 1).
Figure 1. Schematic representation of various differential staining patterns,
showing method used to score sister chromatid exchanges, (a) No 
SCEs are present, (b) A single SCE. The arrow indicates the point 
of reciprocal exchange of the chromatids, (c) Two SCEs. (d) 
Three SCEs. (e) An SCE occurring at the centromere. (Adapted 
from Carrano and Natarajan 1988).
The chromosomes of each metaphase cell were drawn onto paper and were 
colour coded by chromosome group (A to G). Each SCE was indicated by a 
black dot (Appendix 4). The SCEs in each cell were added and the numbers 
were transcribed onto a data capture sheet (appendix 5). The mean number 
of SCEs per cell and per chromosome were then calculated and transcribed 
onto a second data capture sheet (appendix 6) from which the data were 
computerised into a dBase IV file.
SCEs were counted in all metaphase cells where there were less than four 
overlapping chromosomes. A t least 44 of the 46 chromosomes had to be
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present, and there had to be visible differential staining o f the chromatids.
Up to 50 metaphase cells were analysed per subject. In cases where 50 cells 
did not fulfil the criteria, the maximum number o f suitable cells was 
analysed.
2.7 Preparation of data for analysis
A  successful case was defined as follows. Firstly, lymphocytes had to have 
successfully undergone mitotic division, with metaphase cells visible under 
the light microscope. Secondly, at least 15 cells had to fulfil the criteria for 
the clear scoring of SCEs.
The computer packages used for data management and statistical analysis 
were dBase IV and Epiinfo.
Data were first analysed to test whether the successful cases were 
representative o f the sample that had been selected from the total exposed 
and unexposed populations. This was done by comparing:
1. A ll successful unexposed cases (21) with all unsuccessful unexposed 
cases (33).
2. A ll successful exposed cases (31) with all unsuccessful (80) exposed 
cases.
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These two sets o f analyses were done to test for any statistical differences
in those variables which have previously been shown to a ffect the frequency 
o f SCE, and which were included in the questionnaire. These variables were:
1. Viral diseases during the previous month (influenza, diarrhoea, chicken 
pox).
2. Hepatitis or glandular fever during the previous six months.
3. Immunisations during the previous six months.
4. Medications during the previous three months (including those 
administered by a traditional healer).
5. Current smoking status.
6. Caffeine consumption (tea, co ffee and cold drinks).
7. Alcohol consumption.
8. Use o f hair dyes during the previous three months.
9. Use o f artificial sweeteners during the previous three months.
Frequency distributions were calculated for differences between the 
successful exposed and unexposed cases with regard to demographic data and 
factors known to a ffect SCE frequency.
Indices were calculated for smoking habits, and for caffeine and alcohol 
consumption. The smoking index was calculated by adding the number of 
commercial and hand rolled cigarettes currently smoked per day. Pipe
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smoking was ignored as only four of the 165 cases smoked a pipe (only one 
o f which was a successful case). The alcohol index was calculated on the 
basis o f the percentage of alcohol contained in a standard glass of wine (15% 
in 150ml, equivalent to 22.5g of alcohol), a tot o f liquor (43% in 25ml, 
equivalent to 10.75g of alcohol), a can of beer (5% in 340ml, equivalent to 
17g o f alcohol), and carton of sorghum beer (2% in 1 000ml, equivalent to 
20g of alcohol). The calculated daily amount of caffeine consumed was based 
on the caffeine content o f an average cup of coffee (85mg), average cup of 
tea (50mg), and 340ml can o f cola (50mg) (Iserson 1990). Means were 
calculated using only those cases who smoked, drank alcohol, or drank 
caffeine, i.e. zero values were excluded from the calculations.
2.8 Statistical methods
Chi-square analyses were used to test differences between absolute numbers. 
Analysis o f variance (ANOVA) was the method applied to test differences 
between means. When the variances in the samples did not differ, p values 
equivalent to the two sample, two-sided Student*s t test were quoted. When 
the variances did differ, the non-parametric Kruskal-Wallis test was used to 
calculate the p value.
Multiple linear regression analysis was performed to determine which o f the 
following variables were predictors of increased SCE frequency:
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1. Conventional medication in the last three months
2. Traditional medication in the last six months
3. Vaccines in the last six months
4. Use o f hair dye
5. Use of artificial sweeteners
6. Any viral infection within the last six months, viz. influenza, 
diarrhoea, chicken pox, hepatitis, or glandular fever
7. "Environmental” exposure to asbestos - taken as positive if  the person 
had lived in an asbestos area, lived with someone who worked in the 
asbestos industry, cut asbestos while working on a hobby, etc.
8. Age - this was divided into 20 year categories for reasons discussed 
in chapter 1, section 1.8
9. Number of cigarettes currently smoked - divided into non, light, 
moderate, heavy and very heavy smokers
10. Amount o f alcohol consumed - divided into low, moderate and high 
alcohol intake
11. Amount of caffeine consumed - divided into equivalent cups o f coffee
12. Occupational exposure to asbestos - exposed or unexposed cases
The dependent variable was the mean SCE frequency per cell.
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CHAPTER 3: DISCUSSION OF METHODS
3.1 Study subjects
The ratio o f exposed to unexposed subjects in the study was 2:1 (122 exposed 
and 61 unexposed men). It would have been preferable to have equal numbers 
o f exposed and unexposed subjects but the size o f the reference group was 
limited. A  decision was made to include as many o f the asbestos workers as 
possible in the study. This same ratio was used by Sobti and Bhardwaj (1991) 
in a study on cytogenetic damage after exposure to stone dust.
3.2 The use of lymphocytes in cytogenetic analysis
In 1960 Nowell discovered that phytohaemagglutinin (PHA) stimulated T 
lymphocytes to divide in culture. Since then, these mitogen-stimulated blood 
lymphocytes have become the most frequently used cells for cytogenetic 
analysis o f short-term cultures o f peripheral blood taken from subjects by 
venipuncture (Vainio and Sorsa 1981).
Although real in vivo detection of damage can be obtained only from direct 
samples o f dividing human cells, e.g. bone marrow or testicular tissue, the 
use o f these cells has obvious disadvantages. SCE is therefore applied in vitro 
to lymphocytes exposed to certain agents in vivo (Vainio and Sorsa 1981). 
Circulating T lymphocytes are easy to obtain and they grow well in culture 
so that the chromosomes are easily visible at mitosis (Crossen 1982b).
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Most o f the T lymphocytes belong to the redistributional pool, i.e. they leave
the blood, pass through the different organs, carrying nutrients and 
metabolites, and reenter the peripheral blood (Carrano and Natarajan 1988). 
Thus, lymphocytes exposed to a mutagen anywhere in the body can 
eventually occur in peripheral blood and can therefore be used as indicators 
of exposure (Carrano 1986). In other words, the lymphocyte is a surrogate 
cell that may be an indicator o f an e ffec t produced in other cells o f the 
body, including germ cells.
3.3 The role of 5-Bromodeoxyuridine in the production of sister chromatid 
exchange
All techniques for SCE visualisation rely on the fact that DNA synthesis in 
eukaryotic cells is semi-conservative and, after two rounds o f DNA synthesis 
in the presence o f either labelled or analogue forms o f thymidine, there will 
be SCEs in the same chromosome which are different in their thymidine 
residue composition (Du Frain 1984).
Almost all methods for the in vitro detection of SCE use the incorporation 
o f 5-Bromodeoxyuridine (BrdU), an halogenated thymidine analogue, for two 
cell cycles, to enable the visualisation o f the exchanges under a light 
microscope (fig. 2). When the cells are stimulated to divide by PHA, BrdU 
is incorporated into the DNA instead o f thymidine. If cells undergo two 
consecutive rounds o f replication in the presence o f BrdU, the second
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generation metaphase chromosomes will contain one chromatid with similar 
DNA strands (either both substituted or both unsubstituted) while the other 
chromatid has a hybrid DNA strand with one chain substituted and one chain 
unsubstituted (Schvartzman and Tice 1982).
Figure 2. Diagrammatic representation of sister chromatids with
bromodeoxyuridine substitution. DNA strands are labelled 1 to 
4. (a) A chromosome that has replicated twice in BrdU without 
forming an SCE. Strands 1,2 and 4 have BrdU incorporated in 
them. The chromatid containing strands 3 and 4 (one strand 
without BrdU and one strand with BrdU) stains dark, relative to 
the sister chromatid (BrdU present in both strands), (b) A 
chromosome with three SCEs. Segments have switched between 
strands 1 and 3, and also between strands 2 and 4, to maintain 
DNA polarity. (Adapted from Carrano 1986).
The lesser substituted chromatid can be made to stain (or fluoresce) either 
more or less intensely than the more substituted one, resulting in 
chromosomes with one chromatid staining darker (or fluorescing more 
brightly) than the other. Thus, exchanges appear as sharp demarcations in the 
intensity o f staining along a chromatid with the opposite staining pattern on 
the other chromatid.
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Latt (1973), using autoradiography to assess the incorporation of tritiated 
BrdU and Hoechst 33258 to achieve sister chromatid differentiation, 
concluded that the dull-fluorescing chromatids had incorporated nearly twice 
as much BrdU as the brightly fluorescing ones. Soon after, other 
fluorochromes, such as acridine orange (Kato 1974c), were also shown to 
differentiate sister chromatids. Staining techniques based on the use o f 
Giemsa (Perry and W olff 1974, Korenberg and Freedlender 1974, Goto 
1978) have largely replaced fluorescent techniques as the former allow the 
preparation of permanent microscope slides and fluorescent microscopy is 
not needed. Unifilarly BrdU substituted chromatids stain darkly with Giemsa, 
whereas bifilarly substituted chromatids stain lightly.
3.4 Factors influencing sister chromatid exchange in culture
Reproducibility o f individual results, at least between laboratories, tends to 
be poor, probably due to the different conditions under which cells are 
cultured, and the different SCE techniques used.
A  number o f technical problems arise during the SCE procedure. Cells must 
survive until the second division to be counted or the response will be biased 
due to the non-survival o f severely damaged cells. In addition, since the 
number o f SCEs increases with increasing concentration o f BrdU in culture 
(Kato 1974c, Davidson et al. 1980), it is important to control baseline 
conditions and to keep the BrdU at a concentration low enough to maintain
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a low baseline exchange rate, but high enough to be able to distinguish
between chromatids.
Some authors believe that a high cell density in the culture may result in a 
lower SCE frequency because a smaller amount o f BrdU will be available 
(Stetka and Carrano 1977, Mazrimas and Stetka 1978, Carrano 1980).
However, Davidson et al. (1980) found that the ratio o f exogenous BrdU 
molecules to cell number had no significant e ffec t on the frequency of SCEs.
A fter addition of BrdU to a cell culture, the culture must be protected from 
visible light as this can increase the frequency o f SCE (Kato 1974b, Ikushima 
and Wolf 1974, Schvartzman et al. 1979). Exposure o f cultures to other than 
red or yellow light causes photolysis o f the BrdU-substituted DNA (Carrano 
and Natarajan 1988).
Morgan and Crossen (1981) found that the culture medium used can influence 
the number o f SCEs. The e ffec t could, to some extent, be dependent upon 
the amount o f thymidine in the medium. Bianchi et al. (1979), however, found 
no difference between Ham's F10 which contains thymidine, and RPMI 1640 
and Dulbecco's MEM, which do not.
Morgan and Crossen (1981) tested two different sera; neither caused an 
increase in SCE. Kato and Sandberg (1977) and McFee and Sherrill (1981), on
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the other hand, have demonstrated variations in SCE frequency with
different batches of serum. This may indicate that some batches o f serum 
contain factors that increase SCE.
Other factors that a ffect SCE frequency are rises in temperature during 
incubation o f cell cultures (Livingston and Dethlefsen 1979, Abdel-Fadil 
al. 1982), and differing incubation times o f cell cultures (Santesson et al. 
1979). The e ffec t o f time is prevented, as much as possible, by incubating 
cultures for a standard period of 72 hours for SCE analysis.
Because o f these factors, it is essential that standardised culture conditions 
be applied, and that control cultures be processed simultaneously.
Taken together, the culture and biological factors (as discussed in chapter 
1) that potentially confound the baseline SCE frequency in humans, are 
numerous. It is therefore not surprising that considerable variation exists 
among individuals.
3.5 The scoring of sister chromatid exchange
An SCE may be defined as a reciprocal exchange between sister chromatids 
o f the same chromosome, shown by differences in staining intensity (Block 
1982a). Each exchange o f stain (a darkly stained region on one chromatid, 
accompanied by a reciprocal lightly stained region on the other chromatid)
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is counted as an SCE (Figure 1). Exchanges o f stain at the centromere are 
counted as an SCE unless there is an obvious twist o f the chromatids 
(Carrano and Natarajan 1988).
Multiple closely spaced SCEs or very small SCEs may be difficult to detect 
and accurately count; their detection is dependent upon the staining quality 
o f the cells (Morgan and Crossen 1981). It is often difficult to judge whether 
or not an SCE has occurred at the centromeric region. Variations in SCE 
frequencies in otherwise identical experiments may therefore be due to some 
extent to variations in staining technique and scoring procedures among 
observers. One should, ideally, have a single scorer during the entire study 
to avoid observer bias.
Kato (1977) suggested that SCEs be counted per cell and not per chromosome 
because baseline SCE is directly related to DNA content and not to 
chromosome number. Swierenga eta/. (1991), however, state that the number 
of SCEs per cell tends to be a more accurate parameter since it does not 
change with the number of chromosomes which may vary from cell to cell. 
For this reason, and because data are not consistently reported in one way 
or the other in different studies, the data in this study are presented as both 
SCE per chromosome and SCE per cell.
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3.6 Statistical methods
The recommended number of cells to examine to detect small differences in 
SCE frequency with statistical confidence, varies from between 10 and 20 
per subject, for a liberal criterion o f accuracy (Hirsch 1984, Block
1982b), to 50 cells, for a strict criterion o f accuracy (Hirsch et al. 1984).
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CHAPTER 4: RESULTS
4.1 Response and success rates
The total number o f subjects in the study was 183; 122 were exposed to 
asbestos and 61 were not exposed (Table 4). The response rate o f both groups 
was high, viz. 91.0% for the exposed group and 88.5% for the unexposed 
group (90.2% overall). Only 18 people did not have blood taken for 
lymphocyte culturing. Reasons for this included refusal, absenteeism, and 
difficulty in taking a blood sample.
TABLE 4. Sample sizes and success rates
Unexposed Factory A Factory B Total
Population
Sample
63
61 (96.8%)
61
61 (100.0%)
115
61 (53.0%)
239
183 (76.6%)
Refusal 
Absent 
Unable to 
draw blood
4 (6.6%) 
3 (4.9%) 
0
2 (3.3%) 
2 (3.3%) 
2 (3.3%)
1 (1.6%) 
1 (1.6%) 
3 (4.9%)
7 (3.8%) 
6 (3.3%) 
5 (2.7%)
No. cultures 
No. successful 
cases
54 (88.5%) 
21 (38.9%)
55 (90.2%) 
11 (20.0%)
56 (91.8%) 
20 (35.7%)
165 (90.2%) 
52 (31.5%)
Table 4 also shows the success rates of the blood cultures, as defined in
chapter 2, section 2.7. These were disappointing in both the exposed and the
unexposed groups (27.9% and 38.9%, respectively). The overall success rate
was 31.5%.
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4.2 Testing for representativeness of successful cases
To test whether the successful cases were representative of the samples of 
exposed and unexposed cases, two comparisons were made. A ll successful 
unexposed cases (21) were compared with all unsuccessful unexposed cases 
(33), and all successful exposed cases (31) were compared with all 
unsuccessful (80) exposed cases. The variables tested are discussed in chapter 
2, section 2.7.
More detailed analyses (see chapter 2 for methodology) were then carried out 
on the successful exposed cases (31) and the successful unexposed reference 
group (21). Statistically significant differences are indicated in all tables by 
bold p values.
4.2.1 Comparison between successful and unsuccessful unexposed 
cases
Table 5a shows the differences between the successful and unsuccessful 
unexposed cases for those variables known to a ffect sister chromatid 
exchange frequency. There were no statistically significant differences 
although more of the successful cases were taking some sort o f conventional 
medication (47.6% as opposed to 24.2% of the unsuccessful cases), and more 
of the successful cases smoked. Most o f these unexposed cases had had an X 
ray in the past year, and most o f them drank tea and/or coffee on a daily 
basis.
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TABLE 5a. Comparison between successful and unsuccessful unexposed cases
Successful Unsuccessful p value*
n = 21 n * 33
Medical:
Influenza 7 (33.3%) 10 (30.3%) 0.8749
Diarrhoea 6 (28.6%) 10 (30.3%) 0.8370
Chicken pox 1 (4.8%) 1 (3.0%) 1.0000
Hepatitis 0 2 (6.1%) 0.5157
Glandular fever 0 0
Any viral disease 12 (57.1%) 17 (51.5%) 0.6887
Exposures:
X rays 20 (95.2%) 31 (93.9%) 1.0000
Medication (non traditional) 10 (47.6%) 8 (24.2%) 0.0784
Medication (traditional) 4 (19.1%) 9 (27.3%) 0.4947
Immunizations 0 1 (3.0%) 1.0000
Hair dye 2 (9.5%) 1 (3.0%) 0.5530
Artificial sweeteners 1 (4.8%) 0 0.3889
Environmental asbestos 3 (14.3%) 2 (6.1%) 0.3660
Smoking:
Cigarettes (commercial) 16 (76.2%) 17 (51.5%) 0.0724
Cigarettes (hand rolled) 4 (19.1%) 2 (6.1%) 0.1933
Pipe 0 0
Marijuana 1 (4.8%) 4 (12.1%) 0.6377
Caffeine:
Tea or coffee 18 (85.7%) 30 (90.9%) 0.6673
Cold drinks 15 (71.4%) 23 (69.7%) 0.8929
Alcohol 11 (52.4%) 19 (57.6%) 0.7106
* Mantel-Haenszel Chi-square test or Fisher exact test
Table 5b shows the differences in the mean ages, number of cigarettes 
smoked, and amount of caffeine and alcohol consumed. The only statistically 
significant difference between the successful and unsuccessful unexposed 
cases was the mean age (p = 0.0016). This difference is, however, probably 
not meaningful with regard to the frequency of sister chromatid exchange 
as baseline SCE frequency appears to be independent o f age (Carrano and 
Moore 1982).
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Successful Unsuccessful p value*
n = 21 n = 33
TABLE 5b. Comparison between successful and unsuccessful unexposed cases (cont.)
mean SD range mean SD range
Age (yrs) 35.9 12.5 18 - 64 47.2 11.5 27 - 72 0.0016
Cigarettes (no./day) 9.4 5.9 1 - 20 12.2 6.8 3 - 2 0 0.2516
Caffeine (mg/day) 186.5 139.6 14.3 - 490.7 190.5 110.5 7.1 - 557.1 0.9066
Alcohol (g/day) 28.2 18.4 5.7 - 72.9 37.4 23.1 4.9 - 85.3 0.2679
* Student’s t test
4.2.2 Comparison between successful and unsuccessful exposed 
cases
As shown in Table 6a, there was a statistically significant difference in the 
proportion o f successful and unsuccessful exposed cases with diarrhoea (p = 
0.0427). In the questionnaire (appendix 1), however, diarrhoea was not 
defined. There was no way of determining whether the cause was viral, and 
thus whether it was relevant with regard to sister chromatid exchange 
frequency. A  much larger proportion of unsuccessful cases had had an X ray 
in the last year (p = 0.0145). In vivo radiation, however, does not appear to 
increase the frequency o f sister chromatid exchanges, as shown by Pant et 
al. (1976) and Waksvik et al. (1981b). No other statistically significant 
differences were found. More o f the successful cases drank alcohol (71.0%) 
than did the unsuccessful cases (52.5%). As for the unexposed groups, most 
o f the exposed subjects drank tea and/or coffee on a daily basis.
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TABLE 6a. Comparison between successful and unsuccessful exposed cases
Successful Unsuccessful p value
n = 31 n = 80
Medical history:
Influenza 9 (29.0%) 19 (23.8%) 0.5671
Diarrhoea 12 (38.7%) 16 (20.0%) 0.0427
Chicken pox 2 (6.5%) 2 (2.5%) 0.3106
Hepatitis 0 2 (2.5%) 1.0000
Glandular fever 0 7 (8.8%) 0.1873
Any viral disease 18 (58.1%) 36 (45.0%) 0.2187
Exposures:
X rays 3 (9.7%) 26 (32.5%) 0.0145
Medication (non traditional) 14 (45.2%) 27 (33.8%) 0.2698
Medication (traditional) 8 (25.8%) 25 (31.3%) 0.6419
Immunizations 0 0
Hair dye 5 (16.1%) 6 (7.5%) 0.2856
Artificial sweeteners 0 2 (2.5%) 1.0000
Environmental asbestos 2 (6.5%) 7 (8.8%) 1.0000
Smoking:
Cigarettes (commercial) 20 (64.5%) 48 (60.0%) 0.6627
Cigarettes (hand rolled) 3 (9.7%) 8 (10.0%) 1.0000
Pipe 1 (3.2%) 3 (3.8%) 1.0000
Marijuana 8 (25.8%) 12 (15.0%) 0.1858
Caffeine:
Tea or coffee 30 (96.8%) 79 (98.8%) 0.4824
Cold drinks 26 (83.9%) 70 (87.5%) 1.0000
Alcohol 22 (71.0%) 42 (52.5%) 0.0786
* Mantel-Haenszel Chi-square test or Fisher exact test
There were no statistically significant differences in age, cigarette smoking, 
caffeine consumption or alcohol consumption between the successful and 
unsuccessful exposed cases (Table 6b). The successful cases did, however, 
have a slightly higher mean daily caffeine consumption than the unsuccessful 
cases (226.0 and 194.2mg, respectively).
The conclusion reached from these analyses is that the successful cases did 
not d iffer from the unsuccessful ones with respect to factors influencing the 
frequency o f sister chromatid exchange, and that the small sample o f 52 
successful cases is therefore representative of the total sample o f 165.
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TABLE 6b. Comparison between successful and unsuccessful exposed cases (cont.)
Successful Unsuccessful p value
n = 31 n = 80
mean SD range mean SD range
Age (yrs) 34.3 13.2 2 3 - 6 8 37.9 12.7 20 - 66 0.1912
Cigarettes (no./day) 9.9 6.9 2 - 3 0 10.2 6.2 1 - 25 0.8943
Caffeine (mg/day) 226.0 135.7 14.3 - 547.9 194.2 101.8 50.0 - 612.1 0.1799
Alcohol (g/day) 40.2 33.7 9.7 - 174.9 40.8 38.0 2.9 - 187.1 0.9518
* Student's t test
4.3 Comparison between exposed and unexposed successful cases 
The 31 exposed cases with successful sister chromatid exchange scoring in 
at least 15 metaphase cells were compared with the 21 successful unexposed 
cases.
The difference in the proportion o f cases who had an X ray during the 
previous 12 months was statistically significant (Table 7a). As mentioned 
earlier, however, in vivo radiation has not been shown to influence the 
frequency of sister chromatid exchanges (Pant et al. 1976, Waksvik et al. 
1981b). No other statistically significant differences were found, although a 
higher proportion of the unexposed group smoked cigarettes (76.2% compared 
to 64.5% o f the exposed), and more of the exposed group consumed caffeine 
and alcohol.
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TABLE 7a. Comparison between successful exposed and unexposed cases
Unexposed Exposed p value*
n * 21 n = 31
Medical history:
Influenza 7 (33.3%) 9 (29.0%) 0.7440
Diarrhoea 6 (28.6%) 12 (38.7%) 0.4552
Chicken pox 1 (4.8%) 2 (6.5%) 1.0000
Hepatitis 0 0
Glandular fever 0 0
Any viral disease 12 (57.1%) 18 (58.1%) 0.9479
Exposures:
X rays 20 (95.2%) 3 (9.7%) 0.0000
Medication (non traditional) 10 (47.6%) 14 (45.2%) 0.9471
Medication (traditional) 4 (19.1%) 8 (25.8%) 0.7391
Immunizations 0 0
Hair dye 2 (9.5%) 5 (16.1%) 0.6872
Artificial sweetener 1 (4.8%) 0 0.4038
Environmental asbestos 3 (14.3%) 2 (6.5%) 0.6370
Smoking:
Cigarettes (commercial) 16 (76.2%) 20 (64.5%) 0.3754
Cigarettes (hand rolled) 4 (19.1%) 3 (9.7%) 0.4205
Pipe 0 1 (3.2%) 1.0000
Marijuana 1 (4.8%) 8 (25.8%) 0.0670
Caffeine:
Tea or coffee 18 (85.7%) 30 (96.8%) 0.2906
Cold drinks 15 (71.4%) 26 (83.9%) 0.2830
Alcohol 11 (52.4%) 22 (71.0%) 0.1762
* Mantel-Haenszel Chi-square test or Fisher exact test
TABLE 7b. Comparison between successful exposed and unexposed cases (cont.)
Unexposed Exposed p value
n = 21 n = 31
SD range mean SD range
Age (yrs) 35.9 12.5 18 - 64 34.3 13.2 18 - 68 0.6791
Cigarettes (no./day) 9.4 5.9 1 - 20 9.9 6.9 2 -- 30 0.8173
Caffeine (mg/day) 186.5 139.6 14.3 - 490.7 226.0 135.7 14.3 -- 612.1 0.3144**
Alcohol (g/day) 28.2 18.4 5.7 - 72.9 40.2 33.7 9.7 -- 174.9 0.1874
* Student's t test 
** Kruskal-Wal1i s test
On average, the exposed group drank more caffeine (in the form o f tea, 
co ffee and cold drinks) and more alcohol, on a daily basis, than the
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unexposed group (Table 7b). These differences, however, were not 
statistically significant. The mean ages of the two groups were very similar 
(34.3 and 35.9 years for the exposed and unexposed groups, respectively), as 
were the mean number of cigarettes smoked each day (9.9 and 9.4, 
respectively).
4.3.1 Frequency of sister chromatid exchanges in exposed and 
unexposed cases
Figure 3 is a photograph of a metaphase cell from a successful case, clearly 
showing the differentially stained sister chromatids of each chromosome, and 
eight SCEs.
Figure 3. Photograph of a metaphase cell, showing differentiation of sister 
chromatids. Arrows point to exchanges.
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The total number of cells examined for sister chromatid exchange frequency 
in the exposed group was 924, and that in the unexposed group, 681 (Table 
8). An inclusion criterion for statistical analysis was that at least 15 cells 
should have been examined in each case. No more than 50 cells were 
examined in any one case. The mean number o f cells examined was slightly 
higher for the unexposed than for the exposed group (32.4 and 29.8, 
respectively) but the difference was not statistically significant (p *  0.5153).
TABLE 8. Cells examined for sister chromatid exchange
frequency - exposed and unexposed cases
Exposed Unexposed 1 Total
Total no. cellj 924 681 1 605
Mean no. cells 29.8 32.4 30.9
SD 12.5 13.7 12.9
Range 15 - 50 1 5 - 5 0 1 5 - 5 0
Median 27 27 27
Mode 50 50 50
* p = 0.5153
The total number of cells scored for each individual, as well as the total 
SCEs counted, the mean SCE frequency per cell, and the standard deviation 
and range, are presented in appendices 7 and 8.
The mean number of sister chromatid exchanges per chromosome (Table 9) 
and the mean number per cell (Table 10) were analysed for all chromosome 
groups (A  to G). There were no statistically significant differences although, 
overall, the frequencies were slightly higher in the unexposed subjects.
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The formula used to calculate the number o f sister chromatid exchanges per
chromosome for each group was:
Total SCEs in group X 
No. SCEs/chromosome = ------------------------------------
Total no. group X chromosomes
TABLE 9. Mean number of sister chromatid exchanges
per chromosome, per chromosome group
Chromosome Exposed Unexposed p value*
group mean SD mean SD
A 0.412 0.096 0.433 0.101 0.5473
B 0.368 0.085 0.375 0.110 0.8096
C 0.250 0.059 0.257 0.061 0.7118
0 0.152 0.038 0.151 0.041 0.9025
E 0.124 0.034 0.137 0.040 0.2127
F 0.073 0.033 0.070 0.030 0.6817
G 0.034 0.018 0.037 0.025 0.6040
Total 0.214 0.043 0.220 0.050 0.6470
* Student*s t test
For example, in a case where 21 metaphase cells were examined, a total of 
126 (21 x 6) group A  chromosomes would have been screened for sister 
chromatid exchanges. If a total o f 49 SCEs were counted in those 126 
chromosomes, the number o f SCEs per chromosome, for group A, would be 
0.39 (49/126).
The formula used to calculate the number o f sister chromatid exchanges per
cell for each group was:
Total SCEs in group X 
No. SCEs/cell = -----------------------------
Total no. cells
51
In the previous example where 21 metaphase cells were examined and a total
o f 49 SCEs were counted in the 126 group A  chromosomes, the number o f
SCEs per cell, for group A, would be 2.33 (49/21).
TABLE 10. Mean number of sister chromatid exchanges
per cell, per chromosome group
Chromosome Exposed Unexposed p value
group mean SD mean SD
A 2.457 0.571 2.579 0.601 0.5291
B 1.467 0.331 1.497 0.440 0.7787
C 3.731 0.876 3.829 0.927 0.7035
D 0.905 0.226 0.903 0.239 0.9670
E 0.740 0.198 0.808 0.234 0.2600
F 0.287 0.128 0.276 0.117 0.7606
G 0.167 0.090 0.187 0.122 0.5019
Total 9.752 2.006 10.078 2.259 0.5935
* Student*s t test
There was no significant difference in the mean number o f SCEs per cell 
between factory A  (9.56; SD 2.40) and factory B (9.86; SD 1.81) (p = 0.7052).
The mean SCE frequency per cell was calculated for smokers and nonsmokers 
in each group (Table 11). The highest mean SCE frequency per cell was in 
unexposed smokers (10.83, SD 2.33), followed by exposed smokers (10.49, SD 
1.98). Both exposed and unexposed nonsmokers had lower mean SCE 
frequencies (8.59, SD 1.47, and 8.58, SD 1.15, respectively). There was no 
difference in the mean SCE frequency per cell between the exposed and 
unexposed groups, even when controlling for smoking (p = 0.6555 for smokers, 
p = 0.9821 for nonsmokers). When the mean SCE frequencies were analysed
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by smoking status, however, the differences were significant at the 95% 
level, both for the exposed (p = 0.0078) and unexposed (p = 0.0257) groups. 
The difference between smokers and nonsmokers, ignoring exposure status, 
was also highly statistically significant (p = 0.0006).
TABLE 11. Mean sister chromatid exchange frequencies per cell 1n
exposed and unexposed cases, by smoking status
Smokers Non-smokers p value*
n mean SD n mean SD
Exposed group 19 10.49 1.98 12 8.59 1.47 0.0078
Unexposed group 14 10.83 2.33 7 8.58 1.15 0.0257
Overal1 33 10.63 2.11 19 8.59 1.33 0.0006**
* Student’s t test
** Kruskal-Wallis test
4.3.2 Regression analysis
The variables tested in the multiple linear regression analysis are discussed 
in chapter 2.
As shown in Table 12, there was a slightly higher proportion of exposed cases 
in the 20 to 39 year old age group (64.5% compared to 57.1% of unexposed 
cases), and a slightly higher proportion o f unexposed cases in the under 20 
year old group (9.5% compared to 3.2% of exposed cases); these differences 
were not statistically significant.
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TABLE 12. Age categories of successful cases
Age group (yrs) Exposed Unexposed Total
< 20 1 (3.2%) 2 (9.5%) 3 (5.8%)
20 - 39 20 (64.5%) 12 (57.1%) 32 (61.5%)
40 - 59 9 (29.0%) 6 (28.6%) 15 (28.9%)
> 59 1 (3.2%) 1 (4.8%) 2 (3.9%)
Total 31 21 52
The two groups were divided into smoking categories, according to the 
number o f cigarettes smoked per day (Table 13). Light smokers smoked one 
to five cigarettes, moderate smokers six to ten, heavy smokers 11 to 20, and 
very heavy smokers more than 20 cigarettes per day.
There was a slightly higher proportion of non-smokers amongst the exposed 
group (38.7% compared to 33.3%). O f the smokers in the exposed group, most 
(52.6%) were moderate smokers. The unexposed smokers were fairly evenly 
spread across the light, moderate and heavy smoker categories; none were 
very heavy smokers.
TABLE 13. Number of cigarettes smoked per day
Smoking
category
Exposed Unexposed Total
non smoker 
light 
moderate 
heavy
very heavy
12 (38.7%) 
6 (19.4%) 
10 (32.3%) 
2 (6.5%) 
1 (3.2%)
7 (33.3%) 
5 (23.8%) 
5 (23.8%) 
4 (19.1%) 
0
19 (36.5%) 
11 (21.2%) 
15 (28.9%) 
6 (11.5%) 
1 (1.9%)
Total 31 21 52
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Alcohol consumption was divided into three categories. Less than 20mg per 
day was considered to be low consumption; 20 to 79mg, moderate, and 80mg 
or more, high (Table 14). Most o f the unexposed group drank little alcohol 
(61.9%), whereas the majority o f the exposed group (58.1%) consumed a 
moderate amount of alcohol, daily. None o f these differences was 
statistically significant.
TABLE 14. Daily amount of alcohol consumed
Alcohol (g/day) Exposed Unexposed Total
low (0 - 19) 
moderate (20 - 79) 
high (> 79)
12 (38.7%) 
18 (58.1%) 
1 (3.2%)
13 (61.9%) 
8 (38.1%) 
0
25 (48.1%)
26 (50.0%) 
1 (1.9%)
Total 31 21 52
TABLE 15. Daily amount of caffeine consumed 
Caffeine (mg/day) | Exposed | Unexposed Total
< 85 4 (12.9%) 4 (19.1%) 8 (15.4%)
85 - 169 12 (38.7%) 9 (42.9%) 21 (40.4%)
170 - 339 9 (29.0%) 5 (23.8%) 14 (26.9%)
>= 340 6 (19.4%) 3 (14.3%) 9 (17.3%)
Total 31 21 52
The daily amount (mg) o f caffeine consumed, in the form o f tea, co ffee and 
cold drink, was categorised as equivalent to one cup of co ffee (< 85 mg), one 
to less than two cups (85 to 169mg), two to less than four cups (170 to 
339mg), and four or more cups (340 mg or more). As shown in Table 15, the
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proportions were similar in both the exposed and unexposed groups. Most
people drank the equivalent o f two to four cups o f co ffee per day.
The regression model showed that the only significant predictor o f SCE 
frequency was cigarette smoking. Asbestos exposure was a non-contributory 
variable, thus having no e ffec t on the frequency.
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CHAPTER 5: DISCUSSION
There was a small observed difference (3.4%) in the mean SCE frequency per 
cell, between the asbestos-exposed group and the unexposed group. This was 
not a statistically significant difference. Smoking, however, caused a 
significant increase in the SCE frequency per cell, in both the exposed and 
the unexposed groups. These findings are in accordance with three previously 
published SCE studies on the in vivo effects o f asbestos exposure in humans 
(Table 16).
TABLE 16. I n  v i t r o  sister chromatid exchange studies on the in  v i v o effects of asbestos 
exposure in humans
Reference Setting No. of SCE/cell p value
subjects exposed unexposed
mean SD mean SD
Rom et a 7. asbestos 25 workers smokers: 10.51 1.33 10.05 1.66 > 0.0500
1983 Insulation 14 controls nonsmokers: 9.39 1.30 7.79 1.20 0.0020
workers overal1: 10.07 1.40 9.08 1.84 0.0560
Kelsey e t  a h asbestos- 22 workers smokers: 7.40 0.30 7.10 0.30 > 0.0500
1986a exposed
construction
workers
10 controls nonsmokers: 6.30 0.20 6.10 0.20 > 0.0500
Fatma e t  a h asbestos 22 workers smokers: 8.16 0.45 5.73 0.16 < 0.0010
1991 cement
factory
12 controls nonsmokers: 6.63 0.50 3.61 0.14 < 0.0010
Nelson* asbestos 31 workers smokers: 10.49 1.98 10.83 2.33 0.6555
1994 products 21 controls nonsmokers: 8.59 1.47 8.58 1.15 0.9821
factory overal1: 9.75 2.01 10.08 2.26 0.5935
* present study
The four studies in Table 16 are difficult to compare, quantitatively, because 
o f the differences among laboratories in the SCE technique as discussed in 
chapter 3 (cell culturing methods, the concentration of BrdU used, the
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number o f cells read, etc). Nevertheless, there are some similarities in the 
findings and all mean SCE frequencies are within the range o f '’normal” 
baseline levels (Table 1 - chapter 1).
Rom et al. (1983) found the highest mean SCE frequency per cell in asbestos
exposed smokers (10.51, SD 1.33) and the lowest in unexposed nonsmokers 
(7.79, SD 1.20). Differences between workers and controls were statistically 
significant for nonsmokers (20.5%; p = 0.0020) but not for smokers (4.6%; p 
> 0.0500). The overall difference between exposed and unexposed individuals 
was 10.9% (p = 0.0560). The difference between smokers and nonsmokers was 
statistically significant. The means calculated in the present study are very 
comparable with those o f Rom et al., i.e. 9.75 versus 10.49 in exposed 
workers, and 10.08 versus 9.08 in unexposed controls. When stratified by 
smoking status, the means in the two studies are even more comparable.
Kelsey et al. (1986a) found no statistically significant differences between 
asbestos-exposed workers and the unexposed group, for smokers or 
nonsmokers. They did, however, also find differences between smokers and 
nonsmokers (p = 0.01 for exposed, p = 0.03 for unexposed workers).
Fatma et al. (1991) also found the highest mean frequency in exposed 
smokers, and the lowest frequency in unexposed nonsmokers (8.16, SD 0.45, 
and 3.16, SD 0.14, respectively). There were statistically significant
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differences between workers and controls in both the smokers and
nonsmokers (42.4% and 83.7%, respectively; p < 0.001). As for the study by 
Rom et al. (1983), there was a statistically significant difference only
between smokers and nonsmokers.
In contrast to the previous three studies, the highest mean SCE frequency 
per cell in the present study was found in unexposed smokers (10.83, SD 
2.33). Exposed smokers had the second highest mean o f 10.49. As in the 
previous studies, however, the differences between smokers and nonsmokers 
were statistically significant in both the asbestos-exposed group (p = 0.0078) 
and the unexposed group (p = 0.0257). The difference between smokers and 
nonsmokers, regardless o f exposure status, was highly significant (p = 
0.0006). There was no overall statistically significant difference between the 
exposed and unexposed groups, regardless o f smoking status (p = 0.6555 for 
smokers, p = 0.9821 for nonsmokers). This finding is in accordance with that 
o f Kelsey et al. (1986a).
The slightly higher mean SCE frequency in the unexposed group, compared 
to the exposed group, was not in accordance with any o f the other studies. 
Perhaps the asbestos workers underwent a more rigorous preemployment 
examination than did the unexposed group, resulting in a healthier workforce. 
There were no demographic differences (e.g. age, sex and race) between the 
two groups.
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The result o f this study may be a true finding, i.e. perhaps asbestos does not 
cause genetic damage (at least not by a method reflected by the SCE 
technique). On the other hand, it is possible that, either the number o f cells 
analysed for SCE, or the number o f individuals in each group, was too small 
to allow for the detection o f a statistically significant difference. Both these 
parameters a ffect the "sensitivity” o f the study (Hirsch 1984). The
study must be sufficiently sensitive to allow meaningful differences to be 
detected as statistically significant.
Hirsch et al. (1984) have described a method to determine the minimum 
percentage increase in SCE frequency detectable at the 95% level, based on 
the number o f individuals per group and the number o f cells counted per 
individual. Based on their calculations, the present study would allow for the 
detection o f a 12.4% difference in SCE frequency between the exposed and 
unexposed groups. This is calculated on the basis o f an average o f 25 
individuals per group and an average o f 30 cells counted per individual (Table 
5 - chapter 4). In other words, with two independent groups o f 25 subjects 
each, with 30 cells counted per individual, one would be able to detect, as 
statistically significant, a 12.4% or greater increase in baseline SCE rate. 
The observed difference was 3.4% and was therefore not statistically 
significant.
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Other studies on the in vivo cytogenetic effects o f asbestos (Table 16) have 
counted more cells per individual than were counted in this study, but have 
included fewer individuals per group. This latter parameter influences the 
sensitivity o f the study to a greater degree than does the number o f cells 
counted, as it increases the statistical power independent o f the number of 
cells analysed (Hirsch et al. 1984). The sensitivities o f the three previous 
studies in Table 16(14.1%, 13.8% and 13.8%, respectively) are, in fact, lower 
than that o f the present study (12.4%), indicating that perhaps the number 
o f individuals and cells counted were sufficient, after all.
The concept o f sensitivity o f the study based on these parameters may be 
helpful, not only in planning future investigations, but also in interpreting 
"negative" results in SCE studies where too few cells were analysed and a 
small number o f subjects included in each group, as well as "positive" results 
where very large numbers o f cells were analysed per group and very large 
numbers o f subjects included (Hirsch et al. 1984).
One must bear in mind the difference between statistical significance and 
biological significance. It is unlikely that the 3.4% difference detected in 
this study would be biologically significant, especially considering the wide 
variations in SCE frequency between individuals. A  more realistic 
biologically significant difference would be closer to 10%, based on 
recommendations by Wulf (1990).
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Wulf (1990) made certain proposals for action, based on the SCE frequencies 
o f exposed individuals. In the case o f extremely high levels (more than 100% 
above baseline or control level) in a single individual, he recommended that 
close relatives be examined for SCE frequencies. This is mainly for scientific 
reasons as no health effects have been found in family members with high 
SCE frequencies (Wulf et al. 1987). In the case o f a high mean SCE frequency 
(more than a 50% increase) in groups o f exposed employees, they should pass 
a health examination and the workplace should be examined to identify and, 
if possible, eliminate the toxic agent(s). Maximum immediate action should 
be taken to prevent exposure o f the employees. For groups o f employees with 
moderately elevated levels o f SCE frequencies (10 to 50% above controls) 
the source should be searched for and suspected SCE inducing agents 
replaced. If the agent cannot be replaced, protection against exposure should 
be ensured, at least until an evaluation, together with other toxicological, 
epidemiological, and cytogenetic examinations, has been performed. If only 
a limited increase in the SCE rate (less than 10%) is observed, this should 
only give rise to concern if other tests indicate that the agent is hazardous.
The SCE technique provides an opportunity to study the acute consequences 
o f exposure o f man to agents already established as genotoxic (Ashby and 
Richardson 1985). Negative results are not necessarily synonymous with the 
absence o f a mutagenic effect. If cytogenetic effects are evident in exposed 
populations, then it would seem plausible to assume that a possible
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mutagenic or carcinogenic hazard exists. If such effects are absent, it may 
be that the agent in question is only genotoxic in vitro, or that the people 
exposed have been adequately protected.
An additional factor which may contribute to negative results is the 
potential repair o f lesions. SCEs occur during the S phase o f mitosis (Wulf 
1990) which does not take place until the cells are stimulated to divide by 
a mitogen in vitro. For a chromosome lesion to be converted to an SCE, the 
lesion must be present during this DNA synthesis phase. This presents a 
potential problem for the measurement o f SCEs induced in peripheral 
lymphocytes in vivo. Since the lymphocyte must be stimulated to undergo 
DNA synthesis (mitosis) in vitro after it is removed from the circulating 
blood, the SCE-inducing lesions must persist from the time o f exposure in 
vivo until the time o f DNA synthesis in vitro (Carrano 1982). During this 
time, the lesions could be removed through efficient cellular repair, resulting 
in a low or nonmeasurable increase in SCE frequency (Carrano 1982, Carrano 
and Natarajan 1988). Only the few lesions that remained could be expressed 
as chromosome aberrations or SCEs if  they were misrepaired when they 
passed through the S phase in vitro. This is particularly true if  SCEs are 
induced by low-level chronic exposures.
In past studies the greatest cytogenetic damage was observed at the early 
stages o f surveillance; subsequent degrees of damage have reduced roughly 
in proportion to the industrial measures instituted (Ashby and Richardson
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1985). Invariably, new genotoxicity assays are calibrated against the worst- 
case situation. When used later, in settings with lower exposures, the data 
may become equivocal.
The failure to detect an increase in SCE frequency in these asbestos workers 
is therefore probably not due to the inability o f asbestos to induce SCEs in 
human lymphocytes, but rather due to low exposures. Fibre levels ranged 
from 0.2414 to 0.8500 fibres per cmJ in the year preceding the study; and 
from 0.1320 to 0.1726 fibres per cm^ in the year that the data were 
collected (V Yousefi - personal communication). According to the Machinery 
and Occupational Safety Act, the exposure limit for asbestos in the South 
African non-mining asbestos industry is 1 fibre per cm (Department o f 
Manpower 1987). Thus, the workers in the two asbestos-products factories 
had certainly been exposed to low levels o f asbestos fibre during the period 
preceding this study.
On the other hand, the SCE technique may not be the ideal method for 
detecting subclinical adverse health effects from working with asbestos. 
These effects, such as cancer, may be induced by other mechanisms that do 
not involve mutagenic action as depicted by SCEs. Lechner et al. (1985) have 
suggested an alternative mechanism for the development o f mesothelioma, 
an asbestos related cancer most often occurring in the pleura o f the lung. 
They exposed pleural mesothelial cells from healthy adults to asbestos fibres
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which penetrated the cells within two hours of exposure. The exposed cells 
were aneuploid and various chromosome abnormalities were found. The 
authors suggest that the uniquely fluid mesothelial cell cytoskeleton may be 
very easily disturbed by penetrating asbestos fibres which would cause 
chromosome instability, oncogenic activation and, u ltim ately, 
transformation.
Mahmood et al. (1993) recently suggested that the asbestos-mediated 
formation of free radicals in the presence o f peroxides and hypoperoxides 
may be the causative factor o f DNA damage (other chemical carcinogens 
either alkylate or make covalent bonds with DNA). These chromosome 
changes may, in turn, be related to the induction o f lung cancer in asbestos 
exposed individuals.
Potential limitations of the study 
1. Success rate
The success rate o f the cultures, for SCE analysis, was very poor (31.5%). In 
some cases there were too few metaphase cells that met the criteria for SCE 
analysis (less than 15). This was sometimes due entirely to poor growth o f 
the cultures. In other cases, however, there was good growth o f the cultures 
and thus a sufficient number of metaphase cells, but the chromatids had not 
stained differentially. SCEs could therefore not be distinguished and the case 
had to be discarded as ’’unsuccessful". In some cases, not all o f the
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chromatids in a single cell were differentially stained. One explanation is
that the culture period may not have been optimal. A 72 hour culture period 
was used, following standardised SCE methodology, but perhaps some of the 
cells passed through three, instead of only two, cell divisions. The result 
would be that the chromatids of only half o f the chromosomes would be 
distinguishable (Fig. 4). Another problem that reduced the success rate was 
poor spread o f the chromosomes in some cases. One o f the criteria for a 
successful case was that there should be no more than four "overlaps” , and 
cells with more than four overlapping chromosomes therefore had to be 
discarded.
Nevertheless, the successful cases did not differ, statistically, from the 
unsuccessful ones with respect to factors influencing the frequency of sister 
chromatid exchange. The small sample of 52 successful cases was therefore 
taken to be representative of the total initial sample of 165.
/
Figure 4. Progression of cells through three division cycles in the presence of
BrdU. --------Thymidine-bearing DNA strand. ------  BrdU-bearing
strand. Black chromosomal regions indicate segments which stain darker 
with Giemsa. (Adapted from Schvartzman and Tice 1982).
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2. Other exposures
The questionnaires were designed to detect exposure to as many factors 
known to influence SCE frequency as was possible. Nevertheless, it is 
possible that the asbestos workers, or even the unexposed group, were 
exposed to other genotoxic agents which could have affected the SCE 
frequency. Additional exposure histories o f the asbestos-exposed group were 
not taken into account as all subjects had worked in the production side o f 
the asbestos factory for at least six months. As SCE frequencies have been 
found to remain at a high level for four to 16 weeks after exposure, before 
returning to baseline levels (Vainio and Sorsa 1983), previous exposure to 
other chemicals would probably not have affected the SCE frequency in the 
lymphocytes at the time when blood was taken.
4. Control group
The unexposed subjects may have been an inappropriate choice for a control 
group. However, they were o f similar socio-economic status to the exposed 
group, and the two groups did not d iffer in basic demographic 
characteristics, or with respect to exposure to factors known to influence 
SCE frequency.
3. Data analysis
A  two-tailed Student's t test is commonly used for the statistical analysis o f 
group means (Block 1982b). However, the means may not be normally
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distributed and the t test may therefore be inappropriate (Carrano and 
Natarajan 1988). Analysis o f variance or appropriate non-parametric 
statistics may be more rigorous for the particular population under study. 
D ifferent studies have used various methods to transform the data in an 
attempt to normalise the data and thus, have more accurate estimates o f the 
difference in SCE frequencies between populations. Murphy et al. (1992) 
explored the merits o f various methods o f data transformation in SCE 
studies. They concluded that common transformations such as natural 
logarithm, square root, etc. have little advantage in assessing whether an 
agent induces SCEs. As it appears that no statistical procedure can be 
recommended for universal application, the data in this study were not 
transformed. This also enabled comparison with other similar studies.
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CHAPTER 6: CONCLUSION
There is controversy surrounding the rationale for measuring cytogenetic 
changes in humans occupationally or otherwise exposed (Carrano 1986). The 
main concern is whether chromosome damage, as measured in the human 
lymphocyte, predicts an ill health e ffec t for the individual. It has been 
argued that, because there is not a clear understanding o f the significance 
o f increased chromosome damage, it is difficult to interpret the results of 
studies for the individuals being evaluated and, therefore, such studies should 
not be performed in an occupational setting.
The induction o f SCEs in lymphocytes cannot be interpreted as a predictor 
o f an ill-health e ffec t for an individual. Nevertheless, much is known about 
the formation and significance o f cytogenetic changes, and the prediction o f 
an ill-health e ffec t should not be the sole reason for applying cytogenetic 
tests in worker groups. A t the least, cytogenetic changes in an individual are 
markers o f personal exposure and may have an appropriate role in an 
industrial hygiene programme. Furthermore, positive correlations have been 
established between the induction of these endpoints and cytotoxicity, 
mutation, transformation, or tumour formation (Carrano 1986).
SCE analysis remains one of the more sensitive and widely applicable 
short-term tests. Its true value will be enhanced by a better understanding
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o f the mechanism of SCE formation. Real proof o f the significance o f these 
cytogenetic observations, however, can only be obtained in prospective 
epidemiological studies (Vainio and Sorsa 1983). Short-term, followed by 
long-term, genotoxicological monitoring of an exposed population would have 
several advantages. Early cancer diagnosis would be possible and genetic 
counselling could be offered (Brogger 1982e).
While the knowledge o f mutagenicity o f chemicals is gradually increasing, 
and cytogenetic methods are being better standardised to allow for 
interlaboratory correlations, studies of chromosome damage will most 
probably develop as an important tool in controlling unnecessary exposures 
to genotoxic agents in the occupational environment (Sorsa 1985). If the 
cytogenetic endpoint is sufficiently sensitive to levels o f exposure occurring 
in occupational settings, the results could prompt the implementation of 
environmental controls or medical surveillance, even in the absence of direct 
evidence relating the chromosomal effects to adverse health outcomes 
(Stolley et al. 1984).
Finally, the failure to observe an increase in SCE frequency, as in the 
present study on asbestos exposure, does not rule out the agent as a 
genotoxin. Rather, it may help to resolve the limitations o f the SCE method 
for detecting genetic damage.
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CONSENT FORM
APPENDIX 1
NATIONAL CENTRE FOR OCCUPATIONAL HEALTH 
P.O. BOX 4788, JOHANNESBURG. 2000
Tel.; 724-184A
DEPARTMENT OF OCCUPATIONAL MEDICINE
MEDICAL EXAMINATION AND STUDY OF PEOPLE EXPOSED TO ASBESTOS 
Information Form
%
The National •Centre f o r  Occupational Health has been, asked to- give1 all employees, 
at Mintex/Don and Capil full medical examination.
The purpose of this is to see whether employees may have picked up lung scarring 
from inhalaling asbestos.
Ve also want, to iLo- research to find out- whether aeboeton may affect certain cells . 
in the body. This can be measured in the blood.
We therefore ask every employee to take part in the study.
This will involve :
X. .Answering, questions about symptoms and jobs (^'questionnaire"}
2 . Chest X—ray
3. Chest examination by a doctor
/
4. Blowing test ("lung function")
5. Giving a small amount of blood.
There are no harmful effects from these tests, but the blood test may be slightly 
painful.
Any employee found to have a medical problem will be referred to a doctor. If you 
do not hear individually, you can assume your results did not show a medical proble
89
-  2 -
AIL Individual test results are confidential, and will be available to management 
only if needed to apply for workmen's compensation.
Group or "overall" results will be available to management and workers on request.
Taking part is entirely voluntary, and no employee will lose out by taking part*- 
However i* -will be- difficult to aoaour-a properly ~the • effects of the‘asbestos 
exposure if many workers decide not to take part.
Any questions you.may-have w ill be answered by the team from N.C.O.H.
Proposed programme :
September - November 
(Every Monday)
November 17th - 21st :
November 24th - 
December 5th
Questionnaires 
Blood test
Thia will take ± 30_ minutes per employee _
Chest X-ray (± 15 minutes per employee)
Lung-function tests
Chest examination ~ <* 30-mins*- P®r employee)
Thank you for considering this request.
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C O N S E N T F O R M
I *
agree to participate in the study as set out in the Information Form.
Signed
Date:
w itness *
Researcher:
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APPENDIX 2
QUESTIONNAIRE 1 Card 1 [ ]
Clock/Company number [ ] [ ] [ ] [ 1^
DON INTERNATIONAL/CAPIL SURVEY 1986
This survey involves answering questions about your health and occupation, 
as well as taking a blood sample for tests. All your answers will remain 
confidential. You will receive a report (which you can discuss with your 
doctor, if necessary) after the lung function tests and X-rays have been 
completed. We appreciate your co-operation in this project.
a) DATE (dd/mm/yy):
b) INTERVIEWER: (LM=1;RR*2) 
C) LANGUAGE OF INTERVIEW...
d) SURNAME...................
e) FIRST NAMES..............
/ / 1986 [ ] [ ] [ ] [  ] 9 
f ho  
I h i
f) DATE OF BIRTH (dd/mm/yy) •• _  / _  / 19_ I H  It It It 1 [ h ?
g) AGE: [ ] C ] years ' t 1 t 119
h) HOME LANGUAGE (tick one) : N Sotho [1 ] Xhosa [5]
S Sotho [2 ] Tsonga (61
Zulu [3] Other [7]
-
Tswana [4] [ h o
i) SCHOOLING (tick one): nil [1 ] std.6-9 [4]
< std.l [2 ] matric [5]
std.1-5 [3] post-matric [6 ] [ h i
j) PRESENT ADDRESS.
t ] 22
k) ANY OTHER CONTACT ADDRESS.
[ ] 23
1) HAVE YOU EVER BEEN SEEN AT THE NCOH CLINIC IN
JOHANNESBURG? Y [1] N [2]
IF YES, WHEN? month [ ][ ] year 19[ ][ ]
t h 4
N t h
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1. FAMILY HISTORY
1.1 Are/were your parents cousins? 
--- if yes,please specify ---------
Y [1] N [2] [ ]
[ ]
27
28
1.2 Is your father still alive?
--- if yes,please specify
Y [1] N [2] t I 29
Y [1] N [2]
%
t >30
t I t >32
1.4 Is your mother still alive?
--- if yes,please specify
Y tH N [2] t >33
Y [1] N [2] t >34
t I t >36
1.6 How many brothers do you have?
1.7 How many sisters do you have?
M M
M M
1.8 Are all your brothers and sisters still alive?
Y [1] N [2]
1.9 Do/did any of them suffer from any disease?
Y [1] N [2]
--- if yes,please specify
1 ) ..........................................
2 ) .............................................................................................
3) .....................
4) .....................
[ I t  ] 38 
M N 40
t I 4i
t ] 42
C 3 C ]44 
t H  >46 
t 3t ] 48 
t It I50
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1.10 Does/did any member of your immediate family have 
any of the following?
a) chest problems Y [1] N [2]
I— - if yes,please s p e c i f y ---------------------------------
b) cancer Y [1] N [2]
---if yes,please s p e c i f y ----------- - ----------------------
t H  ] 53 
I H  ] 55 
M t  357
t 358
N d f i O
t H  >62
M I  J64
1 . 1 1 Do you have any children? 
if no, go to section 1.17
Y fl] N [2 ]
1 . 1 2 Are you related to your wife? Y tl] N [2 ]
I---if yes,please specify
I 365
I 36 6
I 367
1.13 How many children do you have?
Card 2 I 3i
Clock/Company
number [ ][ ] [ ] [ 3 5
I 3 C 1 t 3 I 17
1.14 What are their ages?
(if fewer than 6 children, 
record ages of youngest 6 )
13  13  
I 31 3 
I 3 I 3 
M i l  
1113  
13  13
13  13 
13  13 
1 3 1 3  
t i l l  
t 3 t 3 
t 3 t 3
9
11
13
15
17
19
1.15 Were any of your children born with a physical
abnormality? Y [1] N [2] t 32q
—  if yes, please specify ------------------------
abnormality:.................. age of child:
abnormality:.................. age of child:
abnormality:.................. age of child:
t 3 t 3 
t 3 t 3 
t 3 t 3
22
24
26
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1.16 Were any of your children born with a mental
abnormality? Y [1] N [2]
--- if yes, please specify --------------------------------
abnormality:.................  age of child:......
abnormality:.................  age of child:......
abnormality:.................  age of child:......
t 1 27
[ ] [  )
[ ] (  ]
C ] C 13
1.17 Have any of your brothers/sisters/children ever 
had a child born with a physical or mental 
abnormality? Y [1] N [2]
---if yes, please s p e c i f y ----------------- ----------------
abnormality:.................  age of child:......
abnormality:.................  age of child:......
abnormality:.................  age of child:......
t ] 34
[ It ] 
M M  
C H  ]
36
38
40
1.18 Have any of your children been stillborn or died 
before 4 weeks of age?- Y [1] N {23
--- if yes ---------------------------------------------------
1.19 How many such children have you had? [ ][ ]
1.20 How many were stillborn before you started
working in the asbestos factory? I ]
1.21 How many were stillborn after you started
working in the asbestos factory? [ ]
[ ] 41
M I  143
[ ] 44 
[ 145
1.22 Has your wife ever had a miscarriage? Y [1] N [2] t 346
-  if y e s --------------------------------------------
1.23 How many miscarriages has she had? [ ] [ 1 47
1.24 How many did she have before you started 
working in the asbestos factory? t ] t 3 48
1.25 How many did she have after you started 
working in the asbestos factory? C ] [ 3 49
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These questions relate mainly to your chest. Try and answer either 
"yes" or "no" to each question. If you are in doubt, answer "no".
2. COUGH
2.1 Do you usually cough first thing in the morning?
Y [1] N [2] [ ] 50
2.2 Do you usually cough during the day, or at night?
Y [1] N [2] [ ] 5 1
I---If yes to either 2.1 or 2 . 2 ---------------------------
2.3 Do you cough like this on most days for as much
as 3 months each year? Y [1] N [2]
2.4 For how many years have you had this? [ ][ ]
t 1 52
H  ] 54
3. PHLEGM
3.1 Do you usually bring up any phlegm from your chest
first thing in the morning? Y [1] N [2] [ Igj
3.2 Do you usually bring up any phlegm from your chest
during the day, or at night? Y [1] N [2] [ ]gg
--- If yes to either 3.1 or 3.2 --------------------------
3.3 Do you bring up this phlegm like this on most 
days for as much as 3 months each year?
/ Y [1] N [2]
3.4 For how many years have you had this? [ ][ ]
[ 1
[ H  1
57
59
4. PERIODS OF COUGH AND PHLEGM
4.1 In the past 3 years, have you had a period of 
increased cough and phlegm lasting for 3 weeks or
more? Y [1] N [2] [ ] 60
—  If yes to 4.1 ------------------------------------------
4.2 Have you had more than one such period?
Y [1] N [2] [ 161
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5. BREATHLESSNESS
5.1 Is the subject disabled from walking by any 
condition other than heart or lung disease?
Y [1] N [2]
--- If yes to 5.1 ------------------------------------------
Describe condition........................................
GO TO QUESTION 6
[ ] 62
t n  ] 64
5.2 Are you troubled by shortness of breath when 
hurrying on level ground or walking up a slight 
hill? Y [1] N [2]
--- If yes to 5.2 --------------------------------------------
5.3 Do you get short of breath when walking with other 
people of your own age on level ground?
Y [1] ' N (2]
[ ] 65
[ ] 6 6
-If yes to 5.3 --------------------------------------------
5.4 Do you have to stop for breath when walking at 
your own pace on level ground? Y [1] N [2] [ ] 67
6 . WHEEZING
6.1 Does your chest ever sound wheezy or whistling?
Y [1] N [2]
—  If yes to 6.1 ------------------------------------------
6.2 Do you get this on most days - or nights?
Y [1] N [2]
6.3 Have you ever had attacks of shortness of breath
with wheezing? Y [1] N [2]
--  If yes to 6.3 ------------------------------------------
6.4 Is / was your breathing absolutely normal
between attacks? Y [1] N [2]
t 3 63
t 369
1 3 70
[ ] 71
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7. CHEST ILLNESS
Card 3 M 1
Clock/Company
number ( ] [ ] [ ] [ ] 5
7.1 During the past 3 years, have you had any chest 
illness which has kept you away from your usual
activities for as much as a week? Y [1] N [2] [ ]g
--- If yes to 7.1 ------------------------------------------
7.2 Did you bring up more phlegm than usual in any of 
these illnesses? Y [1] N [2] t >7
- If yes to 7.2 — —  ---— ------------------------------
7.3 Have you had more than one illness like this in 
the past 3 years? Y [1] N [2] [ ] 3
7.4 Have you ever had, or been told that you have, any
of the following illnesses or complaints? 
a) injury or operation affecting chest? (eg. broken
rib, stab wound) Y [1] N (2 ] ( h
b) heart disease? Y [1] N [2 ] [ h o
c) bronchitis? (sternal pain, bad cough, sputum,
1 week) Y [1] N [2 ] C h i
d) pleurisy? (sharp pain with breathing, no fever)
Y [1] N [2] [ ] 1 2
e) pneumonia? (fever and sharp chest pain, doctor)
Y [1 ] N [2 ] C h 3
f) tuberculosis (TB)? Y [1 ] N C 2 ] [ J14
g) asthma? Y Cl] N C2] C ] 15
h) other chest trouble? Y [1 ] N C2] C h e
details:.................................................  ( ) 1 7
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8. HISTORY OF CHEST ILLNESS IN CHILDHOOD
8.1 Did you have any chest illness before the age of 16?
Y [1] N [2] ( U s
--- if yes, please specify
8.2 Did you have measles as a child? Y [1] N [2]
8.3 Did you have whooping cough as a child?
Y [1] N [2]
t U_9
t >20 
I >21
9. HEALTH STATUS
9.1 Have you been told by a doctor that you have any of the 
following diseases?
a) heart disease
(include high blood pressure) Y [1 ] N [2 ] C J 22
b) kidney disease Y [1 ] N [2 ] t >23
c) arthritis (stiff, painful joints,
for a long time) Y Cl] N [2 ] C J 24
d) sugar sickness / thyroid problems Y 1 1 ] N [2 ] t >25
e) rheumatic fever (swollen joints with
heart disease) Y Cl] N [2 ] t ] 26
f) meningitis (severe headache, fever,
stiff neck, hospitalization) Y Cl] N C2 ] ( >27
9.2 Have you had any of the following illnesses in the
last month?
a) 'flu/cold Y Cl] N [2 ] C ] 28
b) diarrhoea Y Cl] N 1 2 ] C ] 29
c) chickenpox Y [1 ] N [2 ] t >30
9.3 Have you had any painful swelling of the liver
in the last 6 months which developed suddenly
(hepatitis)? Y Cl] N [2 ] t >31
9.4 Have you had glandular fever (swelling of the
glands) in the last 6 months? Y 1 1 ] N C2] t >32
9.5 Have you had any vaccines/immunizations; in
the past 6 months? Y [1 ] N C 2 ] £ >33
--  If yes, please specify ------------------
[ ] [ ]r> ci j i j 35
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9.6 Have you ever been treated for cancer?
Y [1 ] N [2 ] [ ] 36
--- If yes -------------------------
9.7 What type of cancer was it?
9.8 What treatment were you given?
9.9 When were you given this treatment? (mnth/yr -
mnth/yr)
£ n  h a
t H  ] 40
n  c 1 1  1 1  i 44 
i n  n  ][ ]48
9.10 Have you had an X-ray or been exposed to any X-rays 
(at work, in hospital or for treatment) within the 
last 12 months (including teeth X-rays)?
Y [1] N [2] [ 149
9.11 Have you taken any medications (prescribed or non- 
prescribed) in the last 3 months? Y [1] N [2]
--- If yes, please specify---------------------------------
desciption reason for taking it
£ I 50
C ] [  ] 52 
M M 5 4  
M l  156
l H  5 58
9.12 Have you taken any medicines prescribed by a 
traditional doctor in the last 6 months?
Y (1] N [2] [ ] 59
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10. TOBACCO SMOKING
10.1 Have you ever smoked cigarettes? (Yes means more 
than 20 packs of cigarettes in your life or more
than 1 cigarette a day for a year). Y [1] N [2] ( ] g0
— - If yes to 10.1 --------------------------------------------
10.2 Do you now smoke cigarettes? (as of 1 month ago)
Y (1) N [2]
10.3 How old were you when you first started regular
cigarette smoking? [ ][ ] years old
10.4 If you have stopped smoking cigarettes completely, 
how old were you when you stopped?
[ ] C 1 years old
10.5 How many cigarettes do you smoke per day now?
[ 1 t ]
10.6 On average of the entire time you smoked, how many
cigarettes did you smoke per day? [ ][ ]
n m 63
M t  ]65
M t  167 
m m 69
Card 4 [ ]i
Clock/
Company number [ ][ ][ ][ ] 5
10.7 Have you ever smoked a pipe regularly? (Yes means
for at least 1 year). Y [1] N [2]
— - If yes to 1 0 . 7 -------------- ------------- -------------
10.8 Do you now smoke a pipe? (as of 1 month ago)
Y [1] N [2]
10.9 How old were you when you started to smoke a pipe 
regularly? [ ][ ] years old
10.10 If you have stopped smoking a pipe completely, 
how old were you when you stopped?
t ][ I years old
10.11 On the average over the entire time you smoked a 
pipe, how much pipe tobacco did you smoke per 
week? (a standard pouch of tobacco contains 50g)
[ ] t ] g
10.12 How much pipe tobacco are you smoking now?
t ] [ ] g per week
( i s
C ] C 19
M t  l i3 
M t  115
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10.13 Have you ever smoked hand-rolled cigarettes
regularly? (Yes means more than 1 hand-rolled 
cigarette per day for a year). Y [1] N (2]
--- If yes to 10.13 --------------------------------------------
10.14 Do you now smoke hand-rolled cigarettes?
(as of 1 month ago) Y [1] N [2]
10.15 How old were you when you started smoking hand- 
rolled cigarettes regularly? [ ] [ ] years old
10.16 If you have stopped smoking hand-rolled cigarettes 
completely, how old were you when you stopped?
[ ][ ] years old
10.17 How many hand-rolled cigarettes do you smoke per
day now? [ ][ ]
10.18 On average of the entire time you smoked hand-
rolled cigarettes, how many hand-rolled cigar­
ettes did you smoke per week? [ ][ ]
10.19 Have you smoked marijuana, more often than once a 
month, in the last 12 months? Y [1] N [2]
11. CAFFEINE AND ALCOHOL CONSUMPTION
11.1 Do you drink tea or coffee?
--- If yes ---------------------------------
11.2 How many cups of tea per day?
(on average)
11.3 How many cups of coffee per day? 
(on average)
Y [1] N [2]
t l t l  
t 1 t 1
11.4 Do you drink fizzy cold-drinks? (coke, fanta, etc.)
Y til N 12]
- If yes --------------------------------------------------
11.5 How many cans of cold-drink per week? t l t l
(on average)
11.6 Do you drink alcohol? Y [1] N [2] [
-  If y e s -----------------------------------------
11.7 How many cartons of beer/home-brew per 
week? (on average) [ ] [ ] [ ] [ >37
1 1 . 8 How many cans of beer per week? 
(on average) t ] C ] [ ] [ 5 39
11.9 How many glasses of wine per week? 
(on average) ( ] [ ] [ ] [ 1 41
1 1 . 1 0 How many tots/shots of hard liquor per 
(eg. brandy, whisky)
week?
( ] [ ]
%
t ] [ 1 43
12. OTHER
12.1 Have you used hair dye in the last 3 months?
Y [1] N [2]
12.2 Have you used artificial sweeteners in the last 3 
months (eg. saccharin, sweetex, etc)?
Y [1] N (2]
[ ] 44 
[ ] 45
13. COOPERATION OP SUBJECT good [1 ]
poor (2 ] C ] 46
14. COMMENTS
/
[ J47
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APPENDIX 3
QUESTIONNAIRE 2 Card 5 1 ] ,
Clock/
Company number [ 3 ( 3 [ 31 35
OCCUPATIONAL AND EXPOSURE HISTORIES
16. DATS OF INTERVIEW (dd/mm/yy): __ /__ / 1986
17. OCCUPATIONAL HISTORY AT DON/CAPIL
17.1 Information from: subject [1]
records (2 ]
subject and records [3]
17.2 List all departments/jobs at Capil/Don/Cape, starting from 
the earliest
[ ] [ ] [ ] [ ]
C 310
•%v
-A" „ •'
n?:.
"
■
DEPARTMENT/JOB
SSSI38SSISBSCS83SSt8SS8S8«CS3S2883!
I H  1 20
PERIOD
from to 
month,year month,year
!33833SS3S338XS3Z3SXSSS3SS:S3S2S83X:S2
l 3 l 1,191 1[ ] - [ ] t 3,19 C 1 [ ] 18
N t l j o
l 31 1,191 3 M  - [ 31 1,191 J[ 128
3 ’ i n  i40
l 1 l 1,19[ J t ] - t It 3,191 3 t 333
4 .
M l  J50
l 31 3,191 31 3 - t 31 3,19[ 31 148
/
M M 60
l 31 3,19[ 31 3 - t 11 3,19[ 31 353
6‘ M M 70
l 3 l 1,19[ 3 1 1 - 1 3 1 3 , 1 9 1  3 1 168
Card
Co. No. [ 3 1 3
l 11 3,19 £ 31 J - 1 It 3,19 £ 31 3
8 .
M M 25
t 1 l 3,191 3 13 - t 1 t 3,19[ 3 [ ] 23
9.
M M 35
t 31 J ,19 £ 3 1 3 - 1 1 1  3,191 31 133
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18. OTHER ASBESTOS EXPOSURE
18.1 Have you ever lived or spent time in any of the following places?
a) North-Western Cape (eg. Kuruman, Prieska, Postmasburg,
Danielskuil) Y[l] N[2] [ ]36
--- If yes ----------------------------------------------
When were you first there? (year) 19 M M
For how long were you there? (months) M  M  M
n n 38 
' { } [ ] [  ] 41
b) North-Eastern Transvaal, near asbestos mines (eg. Penge, 
Bewaarskloof, Kromellenbogen)? Y[l] N[2] [ ] 42
m
I:
—  If yes — ---------- -------- ----- ------------------
When were you first there? (year) 19 [ ] [ ]
For how long were you there? (months) M  M  M
[ H  ] 44 
t U  JC ]47
18.2 Have you ever lived in the same house/hostel room 
as someone working with asbestos? Y[l] N[2] t ] 48
-- If yes — — '------- -------------
When did this start? (year)
How long did this last? (months)
19 M M  
M  M  M
N t l s f l  
[ H  H  ] 53
18.3 Have you ever cut through asbestos boards, sheeting, 
roofing, etc? Y[l] N[2] C 354
-»•»;* ; s
.'-
'Sif ’
p—  If yes
When did you first do this? (year) 
For how long? (months)
19 M M  
M  M  M
t n  i 56
C ][ ] t 3 59
•7-:
i ns
18.4 Have you ever had any other asbestos exposure
outside work? Y[l] N[2]
—  If yes, specify----- ------------- -—
1 .................................................................................
From m[ ] [ ] y[ ] [ ] to m[ ][ ] y[ ] [ ]
2 .................................................................................
From n( ][ ) y( ][ ] to m[ ][ ] y[ ][ 1
[
[
C
t
% [ ]
] t ] [ ] [ ]
] [ } c ] [ ]
t ]
] [ ] [ 1 1 ]
] [ ] t ] [ ]
65
69
70
74
78
6 1
106
107
19. OTHER JOBS
Card 7 M i
Clock/Company number [ ]( )[ )[ j5
List in order, starting from earliest
COMPANY/ 1 TYPE OF 1 SPECIFIC 1 TYPE(S) OF:
MINE | INDUSTRY | JOB | DUST | FUMES/VAPOUR/
GAS
z s s s s s s s s s s s s s z s s s s s s z s s s s s s s s s r s s s s s s s s s s s s c s c s a s s s a s s s i s s s s s s s s s s s x s x s s s s s s
* ’ i  i i i  i i i  i i j  i i i
PERIOD
YEAR to YEAR
c s s s a s s s s s s s s s s s s s s s s s s s a a s s
19 [ 1 M  to 19 | 11 1
i m I t i i  m I 1 1 1 19 l 1 M  to 19 M  M
1 1 1 1  m | 111 I I I | 19 l 11 1 to 19 ( ) (  )
1 m I m I m I M | 19 [ )( 1 t o 19 | | ( 1
1 l l |  l l |  ( ) |  M | 19 M i l  to 19 M M
6. 1 1 I I
| 19 M  M  to 19 M  M
7. | | |  |
| 19 M  I 1 to 19 M  M
8. | | |  |
| 19 M  M  to 19 M  M
13
21
29
37
45
53
61
69
APPENDIX 4
EXAMPLE OF METHOD FOR SCORING SISTER CHROMATID EXCHANGES
bn 0
\ 6^  /31
»
qt.
4 S ,X “ I ' C
ft 4
I
I 
I
r  1
14
0
NO
v
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d a t a  c a p t u r e  s h e e t  f o r  r e c o r d in g  r a w  d a t a
Company number: _________—
APPENDIX 5
Slide ID Vernier
Chrom . 
n o . A B
Nun
C
yber
D
of £ 
E
>CEs
F G Tot
1 .
2.
3.
•
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14. —
15.
16. t
17.
18.
19.
20.
2 1 .
22.
23.
24 .
i--
---
ii 
■
tl 
M
IIIIIIIIIIII11II
•inCM
ibtotal
: = = =  = = = = :: = = =  :: = = = : = = = : : = = = :: = = = =
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Slide ID
26.
Vernier
Chrom. 
no .
h*—
 ■ ■
 H
1 
II 
1 
II 
>
 
1 
II
B
Nu:
C
mbe r 
D
of ; 
E
SCEs
F
II 
1 
CD 
H 
1 
li
Tot
27.
28.
29. : '
30.
31.
32. %
33.
34 .
35.
36.
37. ?
38.
39.
40.
41 .
42.
43.
44.
/
45. ;
46. : - •
47.
48.
49.
•oin
Total
no
DATA CAPTURE SHEET FOR RECORDING CALCULATED MEANS
Company no. [ ][ ][ ][ ] 6
Total no. cells:
t ] [  3 8
Chromosome
Group
Total
Chromosomes
A [ 3 [ 3 [ 3
B c 3 [ 3 C 3
C c 3 C 3 [ 3
D [ 3 [ 3 1 3
E [ 3 C 3 [ 3
F E 3 C 3 C 3
G C 3t 3 C  3
[ ] [  3 [  3 [ 3
Total
SCEs
No. SCEs/ 
Chromosome
E 3 C 3 E 3 [ 3 / 1 3 C 3
t 3 [  3 C  3 t 3 , [  3 [ 3
[ 3 E  3 C  3 [ 3 / [ 3 C 3
E 3 C 3 E 3 C 3 / [ 3 [ 3
C 3 C  3 C  3 [ 3 / [ 3 [ 3
[ 3 C 3 C 3 C 3 / 1 3 [
[ 3 C 3 C 3 [ 3 / [ 3 [
3 [ 3 C ] [  3 [ 3 / C 3 [
No. SCEs/ 
Cell
[ 3,-[ 3 L J 20
C 3,-[ ] [ 3 32
t 3, 3 [ 3
%
44
[ 3 -[ ] [ 3 56
C 3« 3 [ 3 68
Card no. [ 3[ 3 2  
Company no. [ ][ ][ ][ ] 6
[ 3/C 3[ 3 18
[ 3,C 3C 3 30
Total [ 3 [  3 / t 3 1 3 45
APPENDIX 7
STATISTICS FOR INDIVIDUAL ASBESTOS-EXPOSED SUBJECTS
Study No. No. c e l l s T o ta l SC E s/ce ll
sco red SCEs Mean I SD | Range
139 34 494 14.53 7.15 1 -  30
153 15 182 12.13 5.64 6 - 2 5
182 27 269 9.96 3.10 4 - 1 6
194 19 153 8.05 3.22 3 - 1 4
271 18 208 11.56 4.55 5 - 2 0
304 50 597 11 .94 4.44 4 - 2 4
333 50 603 12.06 4.42 4 - 2 4
338 48 433 9.02 3.96 2 - 2 0
339 21 233 11.10 3.41 5 - 1 7
343 19 146 7.68 3.29 4 - 1 4
347 31 440 14.19 5.15 5 - 2 8
400 31 257 8.29 3.14 3 - 1 8
422 38 446 11.74 4.78 5 - 2 5
512 16 99 6.19 3.84 2 - 1 8
560 50 471 9.42 3.50 3 - 1 9
568 21 185 8.81 3.39 3 - 1 6
594 16 111 6.94 3.85 1 -  13
675 38 254 6.68 3.61 1 -  16
733 20 154 7.70 3.59 1 -  17
743 23 195 8.48 3.62 3 - 1 8
950 46 453 9.85 3.41 4 - 1 6
1109 26 243 9.35 3.10 3 - 1 5
1307 49 486 9.92 3.61 2 - 2 0
1436 15 137 9.13 4.56 1 -  22
1437 50 481 9.62 3.92 2 - 2 0
1443 20 207 10.35 4.07 3 - 2 0
1447 32 277 8.66 2.88 3 - 1 3
1450 17 158 9.29 3.64 5 - 1 8
1451 30 249 8.30 3.79 3 - 1 6
1470 35 389 11.11 4.15 3 - 2 2
1492 19 195 10.26 4.06 5 - 2 1
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APPENDIX 8
STATISTICS FOR INDIVIDUAL UNEXPOSED SUBJECTS
Study No. No. c e l l s T o ta l SC E s/ce ll
sco red SCEs Mean I SD | Range
67 21 186 8.86 3.58 2 - 1 5
138 17 127 7.47 3.36 1 -  14
195 50 591 11.82 5.97 2 - 2 8
221 27 287 10.63 4.75 2 - 2 3
334 23 234 10.17 3.97 3 - 1 8
340 31 226 7.29 3.18 2 - 1 4
456 22 273 12.41 6.24 3 - 2 6
474 31 257 8.29 3.89 1 -  18
490 15 127 8.47 3.86 3 - 1 4
553 15 127 8.47 3.54 3 - 1 5
569 26 356 13.69 5.21 6 - 2 2
741 50 460 9.20 3.41 2 - 1 8
749 50 423 8.46 3.38 1 -  15
797 23 365 15.87 5.69 7 - 2 9
834 50 562 11.24 4.36 4 - 2 0
954 50 620 12.40 4.71 3 - 2 4
981 41 425 10.37 4.22 2 - 2 1
1509 23 167 7.26 2.61 2 - 1 1
1551 47 533 11.34 5.56 5 - 2 6
1642 50 444 8.88 2.96 3 - 1 8
2219 19 172 9.05 2.89 4 - 1 4
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